#SampleID	Label	Patient	Age	Sex	BMI	BMI_category	Smoker	Disease_status	Dg	Drug	Brand	Disease_duration_years	Age_at_diagnosis	Comorbidities	Comorbidity_type	Indication_for_biological_treatment	Past_biological_theraphy	Past_biological_therapy_type	Age_at_diagnosis_category	CD_behaviour	CD_localisation	L4	UC_extent	EIM	EIM_type	Intestinal_surgery	Intestinal_surgery_type	Visit	Visit_num	Week	Week_num	Week_baseline	Date	Aplication	Dose	5ASA	5ASA_type	Immunosuppression	Immunosuppression_type	Corticosteroids	Corticosteroid_type	Other_medication	Other_medication_type	CRP	CRP_category	WBC	PLT	Ferritin	Hb	FC	FC_category	Drug_level	Antibodies	HBI	HBI_num	pMayo	pMayo_num	Disease_severity_scale2	Disease_severity_scale4	Response_scale2	Response_scale3	Responder3	Responder2	Response_scale3_modified	SAE	SAE_localisation	SAE_type	Other_skin_manifestations	Other_skin_manifestation_types	Notes	Start_end	Start_end_combined	SAE_visit_only	Localisation
1_BA_1	1_BA_1	P1	25	F	26.6	overweight	non-smoker	IBD	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	repet_biothrp	IFX	A2	B2	L3	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_1	0	week_0	0	0	02.11.2018	SC	160	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Euthyrox	1.4	low	7	350	25.6	130		NA	0	negative	6	6	CD		inactive	mild	baseline	baseline	non-responder	non-responder	baseline_no_response	non-SAE	none	none	no	none	none	start	start	no	L3
1_BA_2	1_BA_2	P1	25	F	26.6	overweight	non-smoker	IBD	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	repet_biothrp	IFX	A2	B2	L3	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_2	1	week_2	2		16.11.2018	SC	80	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Euthyrox	0.8	low	9.9	304	27.2	136	83	slightly_increased	20	negative	1	1	CD		inactive	remission	response	full_response	non-responder	non-responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L3
1_BA_3	1_BA_3	P1	25	F	27	overweight	non-smoker	IBD	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	repet_biothrp	IFX	A2	B2	L3	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_3	2	week_8	8		27.12.2018	SC	40	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Euthyrox	0.9	low	6.8	297	26.5	131	43	normal	11.7	negative	1	1	CD		inactive	remission	response	full_response	non-responder	non-responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L3
1_BA_4	1_BA_4	P1	25	F	27.3	overweight	non-smoker	IBD	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	repet_biothrp	IFX	A2	B2	L3	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_4	3	week_14	14		07.02.2019	SC	40	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Euthyrox	0.7	low	7.7	334	33	137	115	slightly_increased	9.9	negative	1	1	CD		inactive	remission	response	full_response	non-responder	non-responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L3
1_BA_5	1_BA_5	P1	25	F	27.7	overweight	non-smoker	IBD	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	repet_biothrp	IFX	A2	B2	L3	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_5	4	week_22	22		21.03.2019	SC	40	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Euthyrox	1.2	low	6.4	315	37	139	56	slightly_increased	7.9	negative	1	1	CD		inactive	remission	response	full_response	non-responder	non-responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L3
1_BA_6	1_BA_6	P1	25	F	28	overweight	non-smoker	IBD	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	repet_biothrp	IFX	A2	B2	L3	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_6	5	week_26	26		23.05.2019	SC	40	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Euthyrox	1.7	low	9.7	321	33.9	133	528	significantly_increased	0.2	negative	4	4	CD		inactive	remission	response	partial_response	non-responder	non-responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
1_BA_7	1_BA_7	P1	25	F	28	overweight	non-smoker	IBD	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	repet_biothrp	IFX	A2	B2	L3	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_7	6	week_32	32		18.07.2019	SC	40	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Euthyrox	5.5	low	7.6	373	41.3	137	459	significantly_increased	0.1	negative	5	5	CD		inactive	mild	no_response	no_response	non-responder	non-responder	no_response	SAE	none	herpes	no	none	none	NA	NA	no	L3
1_BA_8	1_BA_8	P1	25	F	28	overweight	non-smoker	IBD	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	repet_biothrp	IFX	A2	B2	L3	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_8	7	week_38	38		13.09.2019	SC	40	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Euthyrox	2.4	low	7.3	363	30.9	143	764	significantly_increased	0.8	negative	6	6	CD		inactive	mild	no_response	no_response	non-responder	non-responder	no_response	non-SAE	none	none	no	none	"perianally_2_drains,_intermittent_purulent_secretions,_joint_pain_and_stiffness"	end	end	no	L3
3_PK_1	3_PK_1	P3	21	F	22.6	normal	non-smoker	IBD	CD	ADA	Imraldi	3	18	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B3	L1	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_1	0	week_0	0	0	07.11.2018	SC	160	no_5ASA	none	no_immunosupp	none	corticoids	Budesonid	yes	B12_Caltrate_HAK	1.8	low	8.6	289	49.2	131	120	slightly_increased	0	negative	3	3	CD		inactive	remission	baseline	baseline	NA	NA	NA	non-SAE	none	none	no	none	none	start	start	no	L1
3_PK_2	3_PK_2	P3	21	F	22.6	normal	non-smoker	IBD	CD	ADA	Imraldi	3	18	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B3	L1	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_2	1	week_2	2		20.11.2018	SC	80	no_5ASA	none	no_immunosupp	none	corticoids	Budesonid	yes	B12_Caltrate_HAK	0.6	low	5.7	289	41.3	136	176	slightly_increased	13.2	positive	3	3	CD		inactive	remission	response	partial_response	NA	NA	NA	SAE	"C,E"	drug_exanthema	yes	itchy_rash_on_the_sides_of_the_torso	"post-application_nausea,_sweating"	NA	NA	no	L1
K42_Z92_1	K42_Z92_1	HC42	27	F	19.5	normal	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	non-SAE	none	none	no	none	none	NA	NA	no	HC
3_PK_3	3_PK_3	P3	21	F	22.6	normal	non-smoker	IBD	CD	ADA	Imraldi	3	18	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B3	L1	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_3	2	week_8	8		03.01.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	B12_Caltrate_HAK	1.7	low	7.4	296	43.2	128	843	significantly_increased	8.4	negative	2	2	CD		inactive	remission	response	partial_response	NA	NA	NA	SAE	"C,E"	drug_exanthema	no	none	none	NA	NA	no	L1
3_PK_4	3_PK_4	P3	21	F	22.6	normal	non-smoker	IBD	CD	ADA	Imraldi	3	18	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B3	L1	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_4	3	week_14	14		14.02.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	B12_Caltrate_HAK	1.1	low	4.9	246	32.4	132	341	significantly_increased	8.4	negative	2	2	CD		inactive	remission	response	partial_response	NA	NA	NA	non-SAE	none	none	yes	post-injection_allergic_exanthema_abdomen_and_legs	none	NA	NA	no	L1
3_PK_5	3_PK_5	P3	21	F	21.9	normal	non-smoker	IBD	CD	ADA	Imraldi	3	18	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B3	L1	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_5	4	week_22	22		08.04.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	B12_Caltrate_HAK	2.3	low	7.1	256	42.8	129	146	slightly_increased	2.3	negative	8	8	CD		active	moderate	response	partial_response	NA	NA	NA	non-SAE	none	none	no	none	none	end	end	no	L1
5_VJ_1	5_VJ_1	P5	33	M	25.6	overweight	non-smoker	IBD	UC	ADA	Imraldi	14	19	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	09.11.2018	SC	160	5ASA	Pentasa	immunosupp	AZA	corticoids	Cortiment	no	none	12.5	high	11.7	393	321.3	165	133	slightly_increased	0	negative	UC		8	8	active	severe	baseline	baseline	NA	NA	NA	non-SAE	none	none	no	none	none	start	start	no	E3
5_VJ_2	5_VJ_2	P5	33	M	25.3	overweight	non-smoker	IBD	UC	ADA	Imraldi	14	19	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_2	1	week_2	2		22.11.2018	SC	80	5ASA	Pentasa	immunosupp	AZA	corticoids	Cortiment	no	none	22.8	high	12.1	322	279.2	153	467	significantly_increased	19.3	negative	UC		8	8	active	severe	no_response	no_response	NA	NA	NA	non-SAE	none	none	no	none	none	NA	NA	no	E3
5_VJ_3	5_VJ_3	P5	33	M	24.7	normal	non-smoker	IBD	UC	ADA	Imraldi	14	19	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_3	2	week_8	8		03.01.2019	SC	40	5ASA	Pentasa	immunosupp	AZA	corticoids	Cortiment	no	none	24.7	high	10.7	374	296.7	149		NA	17.9	negative	UC		8	8	active	severe	no_response	no_response	NA	NA	NA	non-SAE	none	none	no	none	none	withdrawal	end	no	E3
6_HP_1	6_HP_1	P6	41	M	21.4	normal	non-smoker	IBD	UC	ADA	Imraldi	1	40	yes	Gilberts_syndrome	EIM	first_biothrp	none	A2	UC	UC	UC	E3	EIM	sakroiliitis	no_surgery	none	visit_1	0	week_0	0	0	12.11.2018	SC	160	5ASA	Pentasa	no_immunosupp	none	corticoids	Medrol	no	none	6.2	low	12.2	254	166.8	130	788	significantly_increased	0	negative	UC		2	2	inactive	mild	baseline	baseline	responder	responder	baseline_response	non-SAE	none	none	no	none	none	start	start	no	E3
6_HP_2	6_HP_2	P6	41	M	21.4	normal	non-smoker	IBD	UC	ADA	Imraldi	1	40	yes	Gilberts_syndrome	EIM	first_biothrp	none	A2	UC	UC	UC	E3	EIM	sakroiliitis	no_surgery	none	visit_2	1	week_2	2		27.11.2018	SC	80	5ASA	Pentasa	no_immunosupp	none	corticoids	Medrol	no	none	0.5	low	8.2	240	83.6	152	29	normal	18	negative	UC		1	1	inactive	remission	response	full_response	responder	responder	response	SAE	D	acneiform_exanthema	no	none	none	NA	NA	no	E3
6_HP_3	6_HP_3	P6	41	M	22	normal	non-smoker	IBD	UC	ADA	Imraldi	1	40	yes	Gilberts_syndrome	EIM	first_biothrp	none	A2	UC	UC	UC	E3	EIM	sakroiliitis	no_surgery	none	visit_3	2	week_8	8		08.01.2019	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	yes	Vigantol	0.5	low	7	208	98.1	155	33	normal	12.6	negative	UC		0	0	inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E3
6_HP_4	6_HP_4	P6	41	M	22	normal	non-smoker	IBD	UC	ADA	Imraldi	1	40	yes	Gilberts_syndrome	EIM	first_biothrp	none	A2	UC	UC	UC	E3	EIM	sakroiliitis	no_surgery	none	visit_4	3	week_14	14		26.02.2019	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	yes	Vigantol	1.8	low	7.1	338	180.6	151	402	significantly_increased	11.2	negative	UC		2	2	inactive	mild	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	E3
6_HP_5	6_HP_5	P6	41	M	22.3	normal	non-smoker	IBD	UC	ADA	Imraldi	1	40	yes	Gilberts_syndrome	EIM	first_biothrp	none	A2	UC	UC	UC	E3	EIM	sakroiliitis	no_surgery	none	visit_5	4	week_22	22		09.04.2019	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	yes	Vigantol	1.4	low	5.6	273	84.5	151	194	slightly_increased	5.2	negative	UC		1	1	inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E3
6_HP_6	6_HP_6	P6	41	M	22.3	normal	non-smoker	IBD	UC	ADA	Imraldi	1	40	yes	Gilberts_syndrome	EIM	first_biothrp	none	A2	UC	UC	UC	E3	EIM	sakroiliitis	no_surgery	none	visit_6	5	week_26	26		21.05.2019	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	yes	Vigantol	1.2	low	5.9	240	84.3	148	2295	significantly_increased	11.5	negative	UC		2	2	inactive	mild	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	E3
6_HP_7	6_HP_7	P6	41	M	22.3	normal	non-smoker	IBD	UC	ADA	Imraldi	1	40	yes	Gilberts_syndrome	EIM	first_biothrp	none	A2	UC	UC	UC	E3	EIM	sakroiliitis	no_surgery	none	visit_7	6	week_32	32		02.07.2019	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	0.9	low	6.1	237	60.9	139		NA	13.4	negative	UC		1	1	inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E3
6_HP_8	6_HP_8	P6	41	M	22.3	normal	non-smoker	IBD	UC	ADA	Imraldi	1	40	yes	Gilberts_syndrome	EIM	first_biothrp	none	A2	UC	UC	UC	E3	EIM	sakroiliitis	no_surgery	none	visit_8	7	week_38	38		13.08.2019	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	0.6	low	5.7	231	76.3	146	176	slightly_increased	16.6	negative	UC		0	0	inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	end	end	no	E3
7_DL_1	7_DL_1	P7	44	F	19.8	normal	non-smoker	IBD	CD	ADA	Imraldi	19	25	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	14.11.2018	SC	160	no_5ASA	none	no_immunosupp	none	corticoids	Budesonid	no	none	4.5	low	6.7	299	31.6	127	513	significantly_increased	0	negative	0	0	CD		inactive	remission	baseline	baseline	responder	responder	baseline_response	non-SAE	none	none	no	none	none	start	start	no	L1
7_DL_2	7_DL_2	P7	44	F	19.8	normal	non-smoker	IBD	CD	ADA	Imraldi	19	25	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_2	1	week_2	2		28.11.2018	SC	80	no_5ASA	none	no_immunosupp	none	corticoids	Budesonid	no	none	0.5	low	8.1	257	16.2	131	174	slightly_increased	20	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
7_DL_3	7_DL_3	P7	44	F	19.8	normal	non-smoker	IBD	CD	ADA	Imraldi	19	25	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_3	2	week_8	8		09.01.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	no	none	1	low	6.5	191	15.6	128	148	slightly_increased	16.8	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	SAE	D	discreet_erythema	no	none	none	NA	NA	no	L1
7_DL_4	7_DL_4	P7	44	F	19.8	normal	non-smoker	IBD	CD	ADA	Imraldi	19	25	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_4	3	week_14	14		20.02.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	no	none	1	low	6.5	191	15.6	128	218	significantly_increased	16.8	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
7_DL_5	7_DL_5	P7	44	F	19.8	normal	non-smoker	IBD	CD	ADA	Imraldi	19	25	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_5	4	week_22	22		10.04.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	no	none	1.7	low	7.2	243	22.8	126	182	slightly_increased	13.2	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
7_DL_6	7_DL_6	P7	44	F	19.8	normal	non-smoker	IBD	CD	ADA	Imraldi	19	25	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_6	5	week_26	26		09.05.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	no	none	1.7	low	7.2	243	22.8	126	311	significantly_increased	13.2	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
7_DL_7	7_DL_7	P7	44	F	20.9	normal	non-smoker	IBD	CD	ADA	Imraldi	19	25	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_7	6	week_32	32		20.06.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	no	none	0.9	low	7.4	213	18.9	132	130	slightly_increased	15.9	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
7_DL_8	7_DL_8	P7	44	F	20.9	normal	non-smoker	IBD	CD	ADA	Imraldi	19	25	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_8	7	week_38	38		01.08.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	no	none	1.3	low	5.9	208	14.6	129		NA	15.2	negative	1	1	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	end	end	no	L1
9_AM_1	9_AM_1	P9	40	M	22.4	normal	non-smoker	IBD	UC	ADA	Imraldi	3	37	no	none	EIM	first_biothrp	none	A2	UC	UC	UC	E1	EIM	uveitis_sakroiliitis	no_surgery	none	visit_1	0	week_0	0	0	22.11.2018	SC	160	5ASA	Pentasa	immunosupp	AZA	no_corticoids	none	no	none	0.9	low	5.1	207	152.5	136	51	slightly_increased	0	negative	UC		4	4	inactive	mild	baseline	baseline	responder	responder	baseline_response	non-SAE	none	none	no	none	none	start	start	no	E1
9_AM_2	9_AM_2	P9	40	M	22.4	normal	non-smoker	IBD	UC	ADA	Imraldi	3	37	no	none	EIM	first_biothrp	none	A2	UC	UC	UC	E1	EIM	uveitis_sakroiliitis	no_surgery	none	visit_2	1	week_2	2		11.12.2018	SC	80	5ASA	Pentasa	immunosupp	AZA	no_corticoids	none	yes	Maltofer	7.1	low	6.1	281	141.7	132	42	normal	11.2	negative	UC		3	3	inactive	mild	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	upper_respiratory_tract_infection	NA	NA	no	E1
9_AM_3	9_AM_3	P9	40	M	22.4	normal	non-smoker	IBD	UC	ADA	Imraldi	3	37	no	none	EIM	first_biothrp	none	A2	UC	UC	UC	E1	EIM	uveitis_sakroiliitis	no_surgery	none	visit_3	2	week_8	8		29.01.2019	SC	40	5ASA	Pentasa	immunosupp	AZA	no_corticoids	none	yes	Maltofer	8.3	low	3.6	231	304.8	119	23	normal	14.3	negative	UC		3	3	inactive	mild	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	E1
9_AM_4	9_AM_4	P9	40	M	22.4	normal	non-smoker	IBD	UC	ADA	Imraldi	3	37	no	none	EIM	first_biothrp	none	A2	UC	UC	UC	E1	EIM	uveitis_sakroiliitis	no_surgery	none	visit_4	3	week_14	14		14.03.2019	SC	40	5ASA	Pentasa	immunosupp	AZA	no_corticoids	none	yes	Maltofer	0.5	low	3.7	281	403.7	123	60	slightly_increased	16.3	negative	UC		2	2	inactive	mild	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E1
9_AM_5	9_AM_5	P9	40	M	22.4	normal	non-smoker	IBD	UC	ADA	Imraldi	3	37	no	none	EIM	first_biothrp	none	A2	UC	UC	UC	E1	EIM	uveitis_sakroiliitis	no_surgery	none	visit_5	4	week_22	22		25.04.2019	SC	40	5ASA	Pentasa	immunosupp	AZA	no_corticoids	none	yes	Sorbifer	2.7	low	4	198	171.7	135	7	normal	20	negative	UC		1	1	inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	virosis	NA	NA	no	E1
9_AM_6	9_AM_6	P9	40	M	22.4	normal	non-smoker	IBD	UC	ADA	Imraldi	3	37	no	none	EIM	first_biothrp	none	A2	UC	UC	UC	E1	EIM	uveitis_sakroiliitis	no_surgery	none	visit_6	5	week_26	26		11.06.2019	SC	40	5ASA	Pentasa	immunosupp	AZA	no_corticoids	none	yes	Sorbifer	1	low	5.8	243	131.7	139	24	normal	18.1	negative	UC		1	1	inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E1
9_AM_7	9_AM_7	P9	40	M	22.4	normal	non-smoker	IBD	UC	ADA	Imraldi	3	37	no	none	EIM	first_biothrp	none	A2	UC	UC	UC	E1	EIM	uveitis_sakroiliitis	no_surgery	none	visit_7	6	week_32	32		25.07.2019	SC	40	5ASA	Pentasa	immunosupp	AZA	no_corticoids	none	yes	Sorbifer_	0.8	low	5.5	199	124.7	143	36	normal	16.6	negative	UC		1	1	inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	end	end	no	E1
10_VM_1	10_VM_1	P10	45	F	30.8	obesity	smoker	IBD	CD	IFX	Flixabi	1	43	yes	"asthma,_Barretts_esophagus"	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_1	0	week_0	0	0	23.11.2018	IV	5	no_5ASA	none	no_immunosupp	none	corticoids	Budesonid	yes	Nolpaza_Famosan_Caltrate_Viganti_B12_Symbicort_Aerius	4.3	low	8	415	27.6	135	1737	significantly_increased	0	negative	6	6	CD		inactive	mild	baseline	baseline	non-responder	non-responder	baseline_no_response	non-SAE	none	none	no	none	none	start	start	no	L3
10_VM_2	10_VM_2	P10	45	F	30.8	obesity	smoker	IBD	CD	IFX	Flixabi	1	43	yes	"asthma,_Barretts_esophagus"	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_2	1	week_2	2		07.12.2018	IV	5	no_5ASA	none	no_immunosupp	none	corticoids	Budesonid	yes	Nolpaza_Famosan_Caltrate_Viganti_B12_Symbicort_Aerius	1.4	low	7.6	407	29.7	137	90	slightly_increased	20	negative	6	6	CD		inactive	mild	response	partial_response	non-responder	non-responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
10_VM_3	10_VM_3	P10	45	F	31.6	obesity	smoker	IBD	CD	IFX	Flixabi	1	43	yes	"asthma,_Barretts_esophagus"	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_3	2	week_8	8		04.01.2019	IV	5	no_5ASA	none	no_immunosupp	none	corticoids	Budesonid	yes	Nolpaza_Famosan_Caltrate_Viganti_B12_Symbicort_Aerius	0.9	low	6.2	321	21.5	132	59	slightly_increased	20	negative	3	3	CD		inactive	remission	response	full_response	non-responder	non-responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L3
10_VM_4	10_VM_4	P10	45	F	31.6	obesity	smoker	IBD	CD	IFX	Flixabi	1	43	yes	"asthma,_Barretts_esophagus"	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_4	3	week_14	14		01.03.2019	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Nolpaza_Famosan_Caltrate_Viganti_B12_Symbicort_Aerius	1.2	low	5.6	378	28.1	133	226	significantly_increased	2.6	negative	7	7	CD		inactive	mild	no_response	no_response	non-responder	non-responder	no_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
10_VM_5	10_VM_5	P10	45	F	32	obesity	smoker	IBD	CD	IFX	Flixabi	1	43	yes	"asthma,_Barretts_esophagus"	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_5	4	week_22	22		26.04.2019	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Nolpaza_Famosan_Caltrate_Viganti_B12_Symbicort_Aerius	3.9	low	7.4	376	19.3	137	333	significantly_increased	1.5	positive	6	6	CD		inactive	mild	response	partial_response	non-responder	non-responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
10_VM_6	10_VM_6	P10	45	F	32	obesity	smoker	IBD	CD	IFX	Flixabi	1	43	yes	"asthma,_Barretts_esophagus"	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_7	6	week_32	32		01.07.2019	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Nolpaza_Famosan_Caltrate_Viganti_B12_Symbicort_Aerius	7.5	low	7.6	413	17.9	139	125	slightly_increased	0.2	positive	6	6	CD		inactive	mild	no_response	no_response	non-responder	non-responder	no_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
10_VM_7	10_VM_7	P10	45	F	32	obesity	smoker	IBD	CD	IFX	Flixabi	1	43	yes	"asthma,_Barretts_esophagus"	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_8	7	week_38	38		30.08.2019	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Nolpaza_Famosan_Caltrate_Viganti_B12_Symbicort_Aerius	4.3	low	8.2	435	17.2	134	279	significantly_increased	37.3	positive	6	6	CD		inactive	mild	no_response	no_response	non-responder	non-responder	no_response	non-SAE	none	none	no	none	none	end	end	no	L3
12_SK_1	12_SK_1	P12	27	F	19.8	normal	non-smoker	IBD	UC	ADA	Imraldi	10	17	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	26.11.2018	SC	160	5ASA	Asacol	no_immunosupp	none	corticoids	Cortiment	no	none	2.6	low	6.7	373	16.4	128	5019	significantly_increased	0	negative	UC		6	6	active	moderate	baseline	baseline	partial-responder	responder	baseline_partial_response	non-SAE	none	none	no	none	none	start	start	no	E2
12_SK_2	12_SK_2	P12	27	F	19.8	normal	non-smoker	IBD	UC	ADA	Imraldi	10	17	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_2	1	week_2	2		10.12.2018	SC	80	5ASA	Asacol	no_immunosupp	none	corticoids	Cortiment	no	none	0.9	low	7.1	366	18.4	126	5413	significantly_increased	20	negative	UC		4	4	inactive	mild	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	E2
12_SK_3	12_SK_3	P12	27	F	19.8	normal	non-smoker	IBD	UC	ADA	Imraldi	10	17	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_3	2	week_8	8		21.01.2019	SC	40	5ASA	Asacol	no_immunosupp	none	corticoids	Cortiment	no	none	2.5	low	7.5	405	10.3	131	146	slightly_increased	20	negative	UC		3	3	inactive	mild	response	full_response	partial-responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E2
12_SK_4	12_SK_4	P12	27	F	19.8	normal	non-smoker	IBD	UC	ADA	Imraldi	10	17	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_4	3	week_14	14		04.03.2019	SC	40	5ASA	Asacol	no_immunosupp	none	no_corticoids	none	no	none	6.6	low	6	430	8.2	119	360	significantly_increased	17.7	negative	UC		5	5	active	moderate	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	E2
12_SK_5	12_SK_5	P12	27	F	19.8	normal	non-smoker	IBD	UC	ADA	Imraldi	10	17	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_5	4	week_22	22		15.04.2019	SC	40	5ASA	Asacol	no_immunosupp	none	no_corticoids	none	no	none	6.6	low	7.9	445	5.9	111	623	significantly_increased	5.5	negative	UC		6	6	active	moderate	no_response	no_response	partial-responder	responder	no_response	non-SAE	none	none	no	none	none	NA	NA	no	E2
12_SK_6	12_SK_6	P12	27	F	19.8	normal	non-smoker	IBD	UC	ADA	Imraldi	10	17	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_6	5	week_26	26		27.05.2019	SC	40	5ASA	Asacol	no_immunosupp	none	no_corticoids	none	no	none	12.8	high	7.7	455	5.9	106		NA	12.4	negative	UC		6	6	active	moderate	no_response	no_response	partial-responder	responder	no_response	non-SAE	none	none	no	none	none	NA	NA	no	E2
12_SK_7	12_SK_7	P12	27	F	19.5	normal	non-smoker	IBD	UC	ADA	Imraldi	10	17	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_7	6	week_32	32		08.07.2019	SC	40	5ASA	Asacol	no_immunosupp	none	no_corticoids	none	no	none	14.9	high	8.5	430	5.9	110	75	slightly_increased	13.8	negative	UC		2	2	inactive	mild	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	end	end	no	E2
13_SI_1	13_SI_1	P13	44	F	18.4	underweight	non-smoker	IBD	CD	ADA	Imraldi	2	42	no	none	EIM	first_biothrp	none	A3	B2	L3	L4	CD	EIM	joints	surgery	ileocecal_resection	visit_1	0	week_0	0	0	03.12.2018	SC	160	no_5ASA	none	immunosupp	AZA	corticoids	Hydrokortizon	yes	Vasosan_Caltrate	2.2	low	6.9	343	9.9	112	756	significantly_increased	0	negative	6	6	CD		inactive	mild	baseline	baseline	responder	responder	baseline_response	non-SAE	none	none	no	none	none	start	start	no	L3
13_SI_2	13_SI_2	P13	44	F	18.4	underweight	non-smoker	IBD	CD	ADA	Imraldi	2	42	no	none	EIM	first_biothrp	none	A3	B2	L3	L4	CD	EIM	joints	surgery	ileocecal_resection	visit_2	1	week_2	2		17.12.2018	SC	80	no_5ASA	none	immunosupp	AZA	corticoids	Hydrokortizon	yes	Vasosan_Caltrate	0.5	low	5.3	314	9	115	196	slightly_increased	20	positive	5	5	CD		inactive	mild	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
13_SI_3	13_SI_3	P13	44	F	18.4	underweight	non-smoker	IBD	CD	ADA	Imraldi	2	42	no	none	EIM	first_biothrp	none	A3	B2	L3	L4	CD	EIM	joints	surgery	ileocecal_resection	visit_3	2	week_8	8		25.01.2019	SC	40	no_5ASA	none	immunosupp	AZA	corticoids	Hydrokortizon	yes	Vasosan_Caltrate_Sorbifer	0.3	low	6.6	256	34.7	126	43	normal	20	negative	5	5	CD		inactive	mild	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
13_SI_4	13_SI_4	P13	44	F	18.8	normal	non-smoker	IBD	CD	ADA	Imraldi	2	42	no	none	EIM	first_biothrp	none	A3	B2	L3	L4	CD	EIM	joints	surgery	ileocecal_resection	visit_4	3	week_14	14		08.03.2019	SC	40	no_5ASA	none	immunosupp	AZA	corticoids	Hydrokortizon	yes	Vasosan_Caltrate_Sorbifer	0.3	low	5.8	217	45.1	125		NA	20	negative	4	4	CD		inactive	remission	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
13_SI_5	13_SI_5	P13	44	F	18.8	normal	non-smoker	IBD	CD	ADA	Imraldi	2	42	no	none	EIM	first_biothrp	none	A3	B2	L3	L4	CD	EIM	joints	surgery	ileocecal_resection	visit_5	4	week_22	22		18.04.2019	SC	40	no_5ASA	none	immunosupp	AZA	corticoids	Hydrokortizon	yes	Vasosan_Caltarte_Sorbifer	0.3	low	4.8	269	31.1	132	49	normal	20	negative	2	2	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L3
13_SI_6	13_SI_6	P13	44	F	18.8	normal	non-smoker	IBD	CD	ADA	Imraldi	2	42	no	none	EIM	first_biothrp	none	A3	B2	L3	L4	CD	EIM	joints	surgery	ileocecal_resection	visit_6	5	week_26	26		30.05.2019	SC	40	no_5ASA	none	immunosupp	AZA	corticoids	Hydrokortizon	yes	Vasosan_Caltrate	0.2	low	7.7	243	26.8	129	80	slightly_increased	20	negative	2	2	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	endoscopic_stricturotomy	NA	NA	no	L3
13_SI_7	13_SI_7	P13	44	F	18.4	underweight	non-smoker	IBD	CD	ADA	Imraldi	2	42	no	none	EIM	first_biothrp	none	A3	B2	L3	L4	CD	EIM	joints	surgery	ileocecal_resection	visit_7	6	week_32	32		11.07.2019	SC	40	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Vasosan_Caltrate	0.4	low	5.9	290	17	130	130	slightly_increased	20	negative	3	3	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	end	end	no	L3
14_MM_1	14_MM_1	P14	40	F	20.6	normal	non-smoker	IBD	CD	ADA	Imraldi	1	39	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L2	non-L4	CD	EIM	joints_eyes	no_surgery	none	visit_1	0	week_0	0	0	05.12.2018	SC	160	5ASA	Asacol	no_immunosupp	none	corticoids	Cortiment	no	none	0.6	low	9.4	185	8	128	39	normal	0	negative	0	0	CD		inactive	remission	baseline	baseline	responder	responder	baseline_response	non-SAE	none	none	no	none	none	start	start	no	L2
14_MM_2	14_MM_2	P14	40	F	20.6	normal	non-smoker	IBD	CD	ADA	Imraldi	1	39	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L2	non-L4	CD	EIM	joints_eyes	no_surgery	none	visit_2	1	week_2	2		18.12.2018	SC	80	5ASA	Asacol	no_immunosupp	none	corticoids	Cortiment	no	none	0.2	low	6.3	200	8.4	120	25	normal	20	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L2
14_MM_3	14_MM_3	P14	40	F	21.3	normal	non-smoker	IBD	CD	ADA	Imraldi	1	39	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L2	non-L4	CD	EIM	joints_eyes	no_surgery	none	visit_3	2	week_8	8		18.02.2019	SC	40	5ASA	Asacol	no_immunosupp	none	no_corticoids	none	yes	Globifer	1.3	low	8.5	169	7.6	117	9	normal	13.7	negative	1	1	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L2
14_MM_4	14_MM_4	P14	40	F	21.3	normal	non-smoker	IBD	CD	ADA	Imraldi	1	39	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L2	non-L4	CD	EIM	joints_eyes	no_surgery	none	visit_4	3	week_14	14		09.04.2019	SC	40	5ASA	Asacol	no_immunosupp	none	no_corticoids	none	yes	Globifer	0.4	low	7.1	169	8.7	123	6	normal	6.7	negative	2	2	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L2
14_MM_5	14_MM_5	P14	40	F	21.3	normal	non-smoker	IBD	CD	ADA	Imraldi	1	39	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L2	non-L4	CD	EIM	joints_eyes	no_surgery	none	visit_5	4	week_22	22		21.05.2019	SC	40	5ASA	Asacol	no_immunosupp	none	no_corticoids	none	no	none	0.8	low	6.1	167	9.3	122	7	normal	14.2	negative	1	1	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L2
14_MM_7	14_MM_7	P14	40	F	21.3	normal	non-smoker	IBD	CD	ADA	Imraldi	1	39	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L2	non-L4	CD	EIM	joints_eyes	no_surgery	none	visit_7	6	week_32	32		13.08.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	no	none	0.5	low	5.6	167	13.3	125	5	normal	20	negative	1	1	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L2
14_MM_8	14_MM_8	P14	40	F	21.3	normal	non-smoker	IBD	CD	ADA	Imraldi	1	39	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L2	non-L4	CD	EIM	joints_eyes	no_surgery	none	visit_8	7	week_38	38		24.09.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	no	none	0.4	low	5	189	6.9	132	10	normal	20	negative	1	1	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	end	end	no	L2
15_SN_1	15_SN_1	P15	25	F	19.6	normal	non-smoker	IBD	CD	ADA	Imraldi	7	18	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L1	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_1	0	week_0	0	0	06.12.2018	SC	160	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Vigantol	1	low	4.8	251	67.3	120	162	slightly_increased	0	negative	0	0	CD		inactive	remission	baseline	baseline	responder	responder	baseline_response	non-SAE	none	none	no	none	none	start	start	no	L1
15_SN_2	15_SN_2	P15	25	F	19.6	normal	non-smoker	IBD	CD	ADA	Imraldi	7	18	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L1	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_2	1	week_2	2		20.12.2018	SC	80	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Vigantol	0.3	low	3.7	266	46.5	112	163	slightly_increased	20	positive	0	0	CD		inactive	remission	response	full_response	responder	responder	response	SAE	C	before_shingles	yes	before_shingles	none	NA	NA	no	L1
15_SN_3	15_SN_3	P15	25	F	19.6	normal	non-smoker	IBD	CD	ADA	Imraldi	7	18	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L1	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_3	2	week_8	8		14.02.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Utrogestan	5.2	low	5.7	265	50.2	117	76	slightly_increased	13.5	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	SAE	C	after_shingles	yes	after_shingles	none	NA	NA	no	L1
15_SN_4	15_SN_4	P15	25	F	20.2	normal	non-smoker	IBD	CD	ADA	Imraldi	7	18	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L1	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_4	3	week_14	14		28.03.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Vigantol	1.3	low	6.8	237	76.7	117	13	normal	20	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
15_SN_5A	15_SN_5A	P15	25	F	20.2	normal	non-smoker	IBD	CD	ADA	Imraldi	7	18	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L1	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_5	4	week_22	22		09.05.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Vigantol	7	low	9	217	46.7	109	82	slightly_increased	20	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
15_SN_7	15_SN_7	P15	25	F	20.2	normal	non-smoker	IBD	CD	ADA	Imraldi	7	18	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L1	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_7	6	week_32	32		30.07.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Vigantol	7	low	9	217	46.7	109	82	slightly_increased	20	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
15_SN_6	15_SN_6	P15	25	F	20.2	normal	non-smoker	IBD	CD	ADA	Imraldi	7	18	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L1	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_6	5	week_26	26		16.06.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Vigantol	3.4	low	8.7	193	18.7	95	46	normal	17.8	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
15_SN_8	15_SN_8	P15	25	F	22.7	normal	non-smoker	IBD	CD	ADA	Imraldi	7	18	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L1	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_8	7	week_38	38		10.09.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Vigantol	0.6	low	9.2	191	13.7	97	6	normal	20	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	end	end	no	L1
16_PT_1	16_PT_1	P16	25	M	29.8	overweight	non-smoker	IBD	UC	IFX	Remsima	12	13	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A1	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	12.12.2018	IV	5	5ASA	Asacol	immunosupp	AZA	no_corticoids	none	yes	Helicid	1.8	low	8.3	218	176.6	158	1636	significantly_increased	0	negative	UC		8	8	active	severe	baseline	baseline	NA	NA	NA	non-SAE	none	none	no	none	none	start	start	no	E3
16_PT_2	16_PT_2	P16	25	M	29.8	overweight	non-smoker	IBD	UC	IFX	Remsima	12	13	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A1	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_2	1	week_2	2		27.12.2018	IV	5	5ASA	Asacol	immunosupp	AZA	no_corticoids	none	yes	Helicid	0.3	low	4.9	205	184.7	153	48	normal	20	negative	UC		7	7	active	moderate	response	partial_response	NA	NA	NA	non-SAE	none	none	no	none	none	NA	NA	no	E3
16_PT_3	16_PT_3	P16	25	M	29.8	overweight	non-smoker	IBD	UC	IFX	Remsima	12	13	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A1	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_3	2	week_8	8		22.01.2019	IV	5	5ASA	Asacol	immunosupp	AZA	no_corticoids	none	yes	Helicid_Vigantol	0.3	low	7.7	229	152.1	167	6000	significantly_increased	20	negative	UC		7	7	active	moderate	no_response	no_response	NA	NA	NA	non-SAE	none	none	no	none	none	NA	NA	no	E3
16_PT_4	16_PT_4	P16	25	M	27.5	overweight	non-smoker	IBD	UC	IFX	Remsima	12	13	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A1	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_4	3	week_14	14		19.03.2019	IV	5	5ASA	Asacol	immunosupp	AZA	no_corticoids	none	yes	Helicid_Vigantol	11.6	high	4.1	186	245.3	154	61	slightly_increased	5.3	negative	UC		5	5	inactive	moderate	response	full_response	NA	NA	NA	non-SAE	none	none	no	none	hospitalisation_TBC	withdrawal	end	no	E3
21_PP_1_IFX	21_PP_1_IFX	P21_IFX	24	F	22	normal	smoker	IBD	CD	IFX	Flixabi	2	23	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_1	0	week_0	0	0	11.01.2019	IV	5	5ASA	Salofalk	no_immunosupp	none	corticoids	Budesonid	yes	Calcichew_Emanera_HAK	9.3	low	9.5	368	59.9	126	1055	significantly_increased	0	negative	7	7	CD		inactive	mild	baseline	baseline	non-responder	non-responder	baseline_no_response	non-SAE	none	none	no	none	none	start	start	no	L3
21_PP_2_IFX	21_PP_2_IFX	P21_IFX	24	F	22	normal	smoker	IBD	CD	IFX	Flixabi	2	23	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_2	1	week_2	2		25.01.2019	IV	5	5ASA	Salofalk	no_immunosupp	none	corticoids	Budesonid	yes	Calcichew_Emanera_HAKA	10.9	high	9.2	310	66.7	124	1072	significantly_increased	12.7	negative	5	5	CD		inactive	mild	response	partial_response	non-responder	non-responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
21_PP_3_IFX	21_PP_3_IFX	P21_IFX	24	F	22	normal	smoker	IBD	CD	IFX	Flixabi	2	23	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_3	2	week_8	8		22.02.2019	IV	5	5ASA	Salofalk	no_immunosupp	none	corticoids	Budesonid	yes	Calcichew_Emanera_HAK	20.9	high	14.5	334	68.5	125	727	significantly_increased	9.8	negative	4	4	CD		inactive	remission	response	partial_response	non-responder	non-responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
21_PP_4_IFX	21_PP_4_IFX	P21_IFX	24	F	22	normal	smoker	IBD	CD	IFX	Flixabi	2	23	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_4	3	week_14	14		16.04.2019	IV	5	5ASA	Salofalk	no_immunosupp	none	corticoids	Budesonid	yes	Calcichew_Emanera_HAK	32.4	high	8.8	335	51.9	134	652	significantly_increased	5.3	negative	3	3	CD		inactive	remission	response	partial_response	non-responder	non-responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
21_PP_5_IFX	21_PP_5_IFX	P21_IFX	24	F	22	normal	smoker	IBD	CD	IFX	Flixabi	2	23	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_5	4	week_22	22		22.01.2019	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA						NA		NA	NA		CD		inactive	NA	NA	NA	non-responder	non-responder	NA	non-SAE	none	none	no	none	none	NA	NA	no	L3
21_PP_6_IFX	21_PP_6_IFX	P21_IFX	24	F	22	normal	smoker	IBD	CD	IFX	Flixabi	2	23	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L3	non-L4	CD	EIM	joints	no_surgery	ileocecal_resection	visit_7	6	week_32	32		18.09.2019	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Emanera_Calcichew_HAK	9.2	low	8.5	389	27.2	130	129	slightly_increased	0.2	positive	5	5	CD		inactive	mild	no_response	no_response	non-responder	non-responder	no_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
21_PP_7_IFX	21_PP_7_IFX	P21_IFX	24	F	22	normal	smoker	IBD	CD	IFX	Flixabi	2	23	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L3	non-L4	CD	EIM	joints	no_surgery	ileocecal_resection	visit_8	7	week_38	38		14.11.2019	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Emanera_Calcichew_HAK	7.8	low	7.2	412	31.2	137	222	significantly_increased	0	positive	5	5	CD		inactive	mild	no_response	no_response	non-responder	non-responder	no_response	non-SAE	none	none	no	none	none	end	end	no	L3
19_DS_1	19_DS_1	P19	28	F	26.7	overweight	non-smoker	IBD	CD	IFX	Remsima	8	21	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B3	L1	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_1	0	week_0	0	0	09.01.2019	IV	5	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Vigantol	8.5	low	8.2	326	14	130	274	significantly_increased	0	negative	1	1	CD		inactive	remission	baseline	baseline	partial-responder	responder	baseline_partial_response	non-SAE	none	none	no	none	none	start	start	no	L1
19_DS_2	19_DS_2	P19	28	F	29.1	overweight	non-smoker	IBD	CD	IFX	Remsima	8	21	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B3	L1	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_2	1	week_2	2		24.01.2019	IV	5	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Vigantol	4.2	low	8.1	281	16.5	135	10	normal	20	negative	4	4	CD		inactive	remission	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L1
19_DS_3	19_DS_3	P19	28	F	29.1	overweight	non-smoker	IBD	CD	IFX	Remsima	8	21	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B3	L1	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_3	2	week_8	8		21.02.2019	IV	5	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Vigantol	7.2	low	6.8	268	7.5	122	93	slightly_increased	20	negative	3	3	CD		inactive	remission	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L1
19_DS_4	19_DS_4	P19	28	F	29.1	overweight	non-smoker	IBD	CD	IFX	Remsima	8	21	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B3	L1	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_4	3	week_14	14		16.05.2019	IV	5	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Vigantol	9.5	low	9.8	297	18	131	113	slightly_increased	1.7	negative	5	5	CD		inactive	mild	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L1
19_DS_5	19_DS_5	P19	28	F	29.1	overweight	non-smoker	IBD	CD	IFX	Remsima	8	21	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B3	L1	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_5	4	week_22	22		01.07.2019	IV	5	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Vigantol	6.3	low	10.7	286	43.8	140	46	normal	2.3	negative	6	6	CD		inactive	mild	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L1
19_DS_6	19_DS_6	P19	28	F	29.1	overweight	non-smoker	IBD	CD	IFX	Remsima	8	21	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B3	L1	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_7	6	week_32	32		05.09.2019	IV	5	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Vigantol	4.8	low	10.7	263	26.4	139	38	normal	1.3	negative	5	5	CD		inactive	mild	no_response	no_response	partial-responder	responder	no_response	non-SAE	none	none	no	none	none	NA	NA	no	L1
19_DS_7	19_DS_7	P19	28	F	31.4	obesity	non-smoker	IBD	CD	IFX	Remsima	8	21	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B3	L1	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_8	7	week_38	38		31.10.2019	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Vigantol	3.6	low	8.8	283	16.8	133	48	normal	1.2	negative	4	4	CD		inactive	remission	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	end	end	no	L1
20_KP_1	20_KP_1	P20	36	F	25.9	overweight	non-smoker	IBD	UC	IFX	Remsima	11	26	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	10.01.2019	IV	5	5ASA	Salofalk	no_immunosupp	none	no_corticoids	none	no	none	2.4	low	10.5	350	23.7	130	4474	significantly_increased	0	negative	UC		6	6	active	moderate	baseline	baseline	NA	NA	NA	non-SAE	none	none	no	none	none	start	start	no	E2
20_KP_2	20_KP_2	P20	36	F	25.9	overweight	non-smoker	IBD	UC	IFX	Remsima	11	26	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_2	1	week_2	2		23.01.2019	IV	5	5ASA	Salofalk	no_immunosupp	none	no_corticoids	none	yes	Algifen	0.4	low	10.7	297	29.8	132	143	slightly_increased	20	negative	UC		1	1	inactive	remission	response	full_response	NA	NA	NA	non-SAE	none	none	no	none	none	NA	NA	no	E2
20_KP_3	20_KP_3	P20	36	F	25.9	overweight	non-smoker	IBD	UC	IFX	Remsima	11	26	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_3	2	week_8	8		20.02.2019	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Vigantol	0.8	low	9.3	293	27.3	130	84	slightly_increased	20	negative	UC		1	1	inactive	remission	response	partial_response	NA	NA	NA	non-SAE	none	none	no	none	none	end	end	no	E2
20_KP_4	20_KP_4	P20	36	F	25.9	overweight	non-smoker	IBD	UC	IFX	Remsima	11	26	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_4	3	week_14	14		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA						NA		NA	UC		NA		NA	NA	NA	NA	NA	NA	NA	SAE	"C,D"	papulopustular_reaction	no	none	switch_to_VEDO	NA	NA	no	E2
22_VE_1	22_VE_1	P22	41	F	22.5	normal	smoker	IBD	CD	IFX	Flixabi	1	40	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	EIM	joints	no_surgery	none	visit_1	0	week_0	0	0	25.01.2019	IV	5	no_5ASA	none	immunosupp	MTX	corticoids	Medrol	yes	Kalnormin_Caltrate_ac_Folicum	1	low	7.4	280	5.2	115	217	significantly_increased	0	negative	4	4	CD		inactive	remission	baseline	baseline	NA	NA	NA	non-SAE	none	none	no	none	none	start	start	no	L1
22_VE_2	22_VE_2	P22	41	F	22.5	normal	smoker	IBD	CD	IFX	Flixabi	1	40	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	EIM	joints	no_surgery	none	visit_2	1	week_2	2		08.02.2019	IV	5	no_5ASA	none	immunosupp	MTX	corticoids	Medrol	yes	Kalnormin_Caltrate_ac_Folicum	0.3	low	6.2	279	8	116	5	normal	20	negative	3	3	CD		inactive	remission	response	partial_response	NA	NA	NA	non-SAE	none	none	no	none	none	NA	NA	no	L1
22_VE_4	22_VE_4	P22	41	F	18.7	normal	smoker	IBD	CD	IFX	Flixabi	1	40	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	EIM	joints	no_surgery	none	visit_3	2	week_8	8		15.03.2019	IV	5	no_5ASA	none	no_immunosupp	none	corticoids	Medrol	yes	Kalnormin_Caltrate	0.6	low	8	247	3	120		NA	12	negative	2	2	CD		inactive	remission	response	partial_response	NA	NA	NA	non-SAE	none	none	no	none	none	NA	NA	no	L1
22_VE_5	22_VE_5	P22	41	F	22.5	normal	smoker	IBD	CD	IFX	Flixabi	1	40	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	EIM	joints	no_surgery	none	visit_4	3	week_14	14		10.05.2019	IV	5	no_5ASA	none	no_immunosupp	none	corticoids	Medrol	yes	Kalnormin_Caltrate	2.3	low	5.7	250	17.5	124	74	slightly_increased	5.4	negative	2	2	CD		inactive	remission	response	partial_response	NA	NA	NA	non-SAE	none	none	no	none	none	withdrawal	end	no	L1
23_SP_1	23_SP_1	P23	44	F	21.2	normal	smoker	IBD	CD	IFX	Flixabi	20	25	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L3	non-L4	CD	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	31.01.2019	IV	5	no_5ASA	none	no_immunosupp	none	corticoids	Prednison	yes	Nolpaza_Caltrate	4.2	low	13.2	470	48.1	128	858	significantly_increased	0	negative	1	1	CD		inactive	remission	baseline	baseline	non-responder	non-responder	baseline_no_response	non-SAE	none	none	no	none	none	start	start	no	L3
23_SP_2	23_SP_2	P23	44	F	21.2	normal	smoker	IBD	CD	IFX	Flixabi	20	25	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L3	non-L4	CD	non-EIM	none	no_surgery	none	visit_2	1	week_2	2		15.02.2019	IV	5	no_5ASA	none	no_immunosupp	none	corticoids	Prednison	yes	Nolpaza_Caltrate_Vigantol	1	low	7.4	522	80.6	129	38	normal	20	negative	2	2	CD		inactive	remission	response	partial_response	non-responder	non-responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
23_SP_3	23_SP_3	P23	44	F	21.2	normal	smoker	IBD	CD	IFX	Flixabi	20	25	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L3	non-L4	CD	non-EIM	none	no_surgery	none	visit_3	2	week_8	8		13.03.2019	IV	5	no_5ASA	none	no_immunosupp	none	corticoids	Prednison	yes	Nolpaza_Caltarte_Vigantol	1.5	low	8.2	480	67.2	125	71	slightly_increased	20	negative	1	1	CD		inactive	remission	response	full_response	non-responder	non-responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L3
23_SP_5	23_SP_5	P23	44	F	22	normal	smoker	IBD	CD	IFX	Flixabi	20	25	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L3	non-L4	CD	non-EIM	none	no_surgery	none	visit_5	4	week_22	22		04.07.2019	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Caltrate_Vigantol	3.3	low	6.8	425	50.3	119	3720	significantly_increased	20	negative	1	1	CD		inactive	remission	response	full_response	non-responder	non-responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L3
23_SP_7	23_SP_7	P23	44	F	22	normal	smoker	IBD	CD	IFX	Flixabi	20	25	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L3	non-L4	CD	non-EIM	none	no_surgery	none	visit_8	7	week_38	38		24.10.2019	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Caltrate_Vigantol	7.5	low	11.1	440	55.9	125	600	significantly_increased	1.9	negative	4	4	CD		inactive	remission	no_response	no_response	non-responder	non-responder	no_response	non-SAE	none	none	no	none	none	end	end	no	L3
24_NA_1	24_NA_1	P24	57	F	30.7	obesity	smoker	IBD	CD	IFX	Remsima	11	47	yes	pulmonary_embolism	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_1	0	week_0	0	0	04.02.2019	IV	5	5ASA	Asacol	no_immunosupp	none	corticoids	Medrol	yes	Controloc_Calcichew_Algifen	8	low	15.2	373	74.1	161	662	significantly_increased	0	negative	8	8	CD		active	moderate	baseline	baseline	partial-responder	responder	baseline_partial_response	non-SAE	none	none	no	none	none	start	start	no	L3
24_NA_2	24_NA_2	P24	57	F	30.7	obesity	smoker	IBD	CD	IFX	Remsima	11	47	yes	pulmonary_embolism	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_2	1	week_2	2		18.02.2019	IV	5	5ASA	Asacol	no_immunosupp	none	corticoids	Medrol	yes	Controloc_Calcichew_Algifen	2.1	low	15.9	320	64.1	157	17	normal	20	negative	7	7	CD		inactive	mild	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
24_NA_3	24_NA_3	P24	57	F	30.1	obesity	smoker	IBD	CD	IFX	Remsima	11	47	yes	pulmonary_embolism	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_3	2	week_8	8		18.03.2019	IV	5	5ASA	Asacol	no_immunosupp	none	corticoids	Medrol	yes	Calcichew	2.7	low	13.5	291	58.3	168	5	normal	20	negative	5	5	CD		inactive	mild	response	full_response	partial-responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L3
24_NA_4	24_NA_4	P24	57	F	30.1	obesity	smoker	IBD	CD	IFX	Remsima	11	47	yes	pulmonary_embolism	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_4	3	week_14	14		13.05.2019	IV	5	5ASA	Asacol	no_immunosupp	none	corticoids	Medrol	yes	Calcichew	2.7	low	12.1	311	52.1	166	29	normal	13.2	negative	2	2	CD		inactive	remission	response	full_response	partial-responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L3
24_NA_5	24_NA_5	P24	57	F	30.4	obesity	smoker	IBD	CD	IFX	Remsima	11	47	yes	pulmonary_embolism	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_5	4	week_22	22		08.07.2019	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	no	none	5.1	low	13.4	298	67.8	159	29	normal	6.2	negative	1	1	CD		inactive	remission	response	full_response	partial-responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L3
24_NA_6	24_NA_6	P24	57	F	30.4	obesity	smoker	IBD	CD	IFX	Remsima	11	47	yes	pulmonary_embolism	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_7	6	week_32	32		30.08.2019	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	no	none	9.4	low	13.4	298	74.3	151	86	slightly_increased	1.9	negative	2	2	CD		inactive	remission	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	end	end	no	L3
25_KB_1	25_KB_1	P25	22	F	20.8	normal	non-smoker	IBD	UC	IFX	Remsima	8	22	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	EIM	joints	no_surgery	none	visit_1	0	week_0	0	0	13.02.2019	IV	5	5ASA	Asacol	immunosupp	AZA	corticoids	Budesonid	no	none	0.4	low	4.6	306	13.4	143	2383	significantly_increased	0	negative	UC		7	7	active	moderate	baseline	baseline	non-responder	non-responder	baseline_no_response	non-SAE	none	none	no	none	none	start	start	no	E3
25_KB_2	25_KB_2	P25	22	F	20.8	normal	non-smoker	IBD	UC	IFX	Remsima	8	22	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	EIM	joints	no_surgery	none	visit_2	1	week_2	2		27.02.2019	IV	5	5ASA	Asacol	immunosupp	AZA	no_corticoids	none	no	none		NA					5336	significantly_increased	11.8	negative	UC		4	4	inactive	mild	response	partial_response	non-responder	non-responder	partial_response	SAE	"C,D"	acneiform_exanthema	no	none	lokalisation_C+_D	NA	NA	no	E3
25_KB_3	25_KB_3	P25	22	F	19.7	normal	non-smoker	IBD	UC	IFX	Remsima	8	22	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	EIM	joints	no_surgery	none	visit_3	2	week_8	8		27.03.2019	IV	5	5ASA	Asacol	immunosupp	AZA	no_corticoids	none	no	none	0.2	low	4.2	207	8.6	142	37	normal	8.9	negative	UC		4	4	inactive	mild	response	full_response	non-responder	non-responder	response	SAE	"C,D"	acneiform_exanthema	no	none	mild_manifestation	NA	NA	no	E3
25_KB_4	25_KB_4	P25	22	F	19.7	normal	non-smoker	IBD	UC	IFX	Remsima	8	22	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	EIM	joints	no_surgery	none	visit_4	3	week_14	14		23.05.2019	IV	5	5ASA	Asacol	immunosupp	AZA	no_corticoids	none	no	none	0.2	low	5.5	225	16.2	140	1007	significantly_increased	3.3	negative	UC		3	3	inactive	mild	response	partial_response	non-responder	non-responder	partial_response	SAE	"C,D"	acneiform_exanthema	no	none	mild_manifestation	NA	NA	no	E3
25_KB_5	25_KB_5	P25	22	F	19.7	normal	non-smoker	IBD	UC	IFX	Remsima	8	22	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	EIM	joints	no_surgery	none	visit_5	4	week_22	22		16.07.2019	IV	5	no_5ASA	none	immunosupp	AZA	no_corticoids	none	no	none	0.4	low	5.1	211	18.2	135	12	normal	2.6	negative	UC		1	1	inactive	remission	response	full_response	non-responder	non-responder	response	SAE	"C,D"	acneiform_exanthema	no	none	mild_manifestation	NA	NA	no	E3
25_KB_6	25_KB_6	P25	22	F	19.7	normal	non-smoker	IBD	UC	IFX	Remsima	8	22	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	EIM	joints	no_surgery	none	visit_7	6	week_32	32		16.09.2019	IV	5	no_5ASA	none	immunosupp	AZA	no_corticoids	none	no	none	1.5	low	5	246	19.1	139	6000	significantly_increased	0.5	negative	UC		5	5	active	moderate	no_response	no_response	non-responder	non-responder	no_response	non-SAE	none	none	no	none	none	end	end	no	E3
26_HP_2	26_HP_2	P26	42	F	21.1	normal	non-smoker	IBD	UC	IFX	Remsima	20	22	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_2	1	week_2	2		05.03.2019	IV	5	no_5ASA	none	no_immunosupp	none	corticoids	Medrol	yes	Helicid	1.1	low	10.1	437	360.9	120	1118	significantly_increased	20	negative	UC		5	5	active	moderate	response	full_response	non-responder	non-responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E3
26_HP_3	26_HP_3	P26	42	F	21.1	normal	non-smoker	IBD	UC	IFX	Remsima	20	22	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_3	2	week_8	8		02.04.2019	IV	5	no_5ASA	none	no_immunosupp	none	corticoids	Medrol	no	none	16.6	high	11.1	373	70.4	130	75	slightly_increased	20	negative	UC		4	4	inactive	mild	response	partial_response	non-responder	non-responder	partial_response	SAE	"C,D"	acneiform_exanthema	no	none	lokalisation_C+_D	NA	NA	no	E3
26_HP_4	26_HP_4	P26	42	F	21.8	normal	non-smoker	IBD	UC	IFX	Remsima	20	22	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_4	3	week_14	14		28.05.2019	IV	5	no_5ASA	none	no_immunosupp	none	corticoids	Medrol	yes	KCL_Caltrate_	4.4	low	6.8	311	35.99	127	152	slightly_increased	18.2	negative	UC		3	3	inactive	mild	response	partial_response	non-responder	non-responder	partial_response	SAE	"C,D"	acneiform_exanthema	no	none	impproved_exanthema_C_and_D_persists	NA	NA	no	E3
26_HP_5	26_HP_5	P26	42	F	21.8	normal	non-smoker	IBD	UC	IFX	Remsima	20	22	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_5	4	week_22	22		23.07.2019	IV	5	no_5ASA	none	no_immunosupp	none	corticoids	Medrol	no	none	1.3	low	4.4	273	36.8	120	7	normal	19.7	negative	UC		4	4	inactive	mild	response	partial_response	non-responder	non-responder	partial_response	SAE	"C,D"	acneiform_exanthema	no	none	impproved_exanthema_C_and_D_persists	NA	NA	no	E3
26_HP_7	26_HP_7	P26	42	F	21.8	normal	non-smoker	IBD	UC	IFX	Remsima	20	22	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_8	7	week_38	38		29.10.2019	IV	5	no_5ASA	none	no_immunosupp	none	corticoids	Budesonid	no	none	2.8	low	6.8	313	51.8	135	1162	significantly_increased	19.1	negative	UC		7	7	active	moderate	no_response	no_response	non-responder	non-responder	no_response	non-SAE	none	none	no	none	residual_manifestations	end	end	no	E3
27_RJ_1	27_RJ_1	P27	19	M	22.2	normal	non-smoker	IBD	CD	ADA	Hulio	6	13	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A1	B3	L3	L4	CD	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	20.02.2019	SC	160	5ASA	Pentasa	immunosupp	AZA	corticoids	Budesonid	no	none	3.4	low	5.2	263	49	152	247	significantly_increased	0	negative	3	3	CD		inactive	remission	baseline	baseline	responder	responder	baseline_response	non-SAE	none	none	no	none	none	start	start	no	L3
27_RJ_2	27_RJ_2	P27	19	M	22.2	normal	non-smoker	IBD	CD	ADA	Hulio	6	13	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A1	B3	L3	L4	CD	non-EIM	none	no_surgery	none	visit_2	1	week_2	2		06.03.2019	SC	80	5ASA	Pentasa	immunosupp	AZA	corticoids	Budesonid	no	none	0.5	low	4	285	43.5	162	36	normal	20	negative	2	2	CD		inactive	remission	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
27_RJ_3	27_RJ_3	P27	19	M	22.4	normal	non-smoker	IBD	CD	ADA	Hulio	6	13	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A1	B3	L3	L4	CD	non-EIM	none	no_surgery	none	visit_3	2	week_8	8		17.04.2019	SC	40	5ASA	Pentasa	immunosupp	AZA	corticoids	Budesonid	no	none	0.3	low	3.7	285	53	165	24	normal	20	negative	2	2	CD		inactive	remission	response	full_response	responder	responder	response	SAE	D	eczema	no	none	"eczema_behind_ears,_face_and_neck_lokalisation_D"	NA	NA	no	L3
27_RJ_4	27_RJ_4	P27	19	M	23.3	normal	non-smoker	IBD	CD	ADA	Hulio	6	13	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A1	B3	L3	L4	CD	non-EIM	none	no_surgery	none	visit_4	3	week_14	14		29.05.2019	SC	40	no_5ASA	none	immunosupp	AZA	corticoids	Budesonid	no	none	0.4	low	3.8	262	48.7	160	13	normal	20	negative	1	1	CD		inactive	remission	response	full_response	responder	responder	response	SAE	D	eczema	no	none	"eczema_behind_ears,_face_and_neck_lokalisation_D"	NA	NA	no	L3
27_RJ_5	27_RJ_5	P27	19	M	23.3	normal	non-smoker	IBD	CD	ADA	Hulio	6	13	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A1	B3	L3	L4	CD	non-EIM	none	no_surgery	none	visit_5	4	week_22	22		10.07.2019	SC	40	no_5ASA	none	immunosupp	AZA	corticoids	Budesonid	no	none	0.3	low	3.9	277	50	167	8	normal	20	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	SAE	D	eczema	no	none	"eczema_behind_ears,_face_and_neck_lokalisation_D"	NA	NA	no	L3
27_RJ_6	27_RJ_6	P27	19	M	23.3	normal	non-smoker	IBD	CD	ADA	Hulio	6	13	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A1	B3	L3	L4	CD	non-EIM	none	no_surgery	none	visit_6	5	week_26	26		20.08.2019	SC	40	no_5ASA	none	immunosupp	AZA	no_corticoids	none	no	none	0.4	low	3	272	62.6	170	4	normal	20	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	SAE	D	eczema	no	none	"eczema_behind_ears,_face_and_neck_lokalisation_D"	NA	NA	no	L3
27_RJ_7	27_RJ_7	P27	19	M	24.8	normal	non-smoker	IBD	CD	ADA	Hulio	6	13	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A1	B3	L3	L4	CD	non-EIM	none	no_surgery	none	visit_7	6	week_32	32		30.09.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	no	none	0.9	low	4	284	39.1	166	8	normal	20	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	SAE	D	eczema	no	none	"eczema_behind_ears,_face_and_neck_lokalisation_D"	NA	NA	no	L3
27_RJ_8	27_RJ_8	P27	19	M	24.8	normal	non-smoker	IBD	CD	ADA	Hulio	6	13	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A1	B3	L3	L4	CD	non-EIM	none	no_surgery	none	visit_8	7	week_38	38		12.11.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	no	none	0.5	low	3.9	284	57.5	165	7	normal	19.5	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	SAE	D	eczema	no	none	"eczema_behind_ears,_face_and_neck_lokalisation_D"	end	end	no	L3
28_WL_1_ADA	28_WL_1_ADA	P28_ADA	35	F	17.8	underweight	non-smoker	IBD	CD	ADA	Hulio	7	28	no	none	EIM	first_biothrp	none	A2	B1	L1	non-L4	CD	EIM	joints	no_surgery	none	visit_1	0	week_0	0	0	28.02.2019	SC	160	no_5ASA	none	immunosupp	MTX	corticoids	Hydrokortizon	no	none	0.6	low	6.8	384	36.6	117	452	significantly_increased	0	negative	7	7	CD		inactive	mild	baseline	baseline	NA	NA	NA	non-SAE	none	none	no	none	none	start	start	no	L1
28_WL_2_ADA	28_WL_2_ADA	P28_ADA	35	F	17.8	underweight	non-smoker	IBD	CD	ADA	Hulio	7	28	no	none	EIM	first_biothrp	none	A2	B1	L1	non-L4	CD	EIM	joints	no_surgery	none	visit_2	1	week_2	2		14.03.2019	SC	80	5ASA	Pentasa	immunosupp	MTX	corticoids	Hydrokortizon	yes	Euthyrox_Calcichew_Omeprazol_Vigantol_Celecoxib_Doreta_folate	0.2	low	9.3	343	20.5	122	257	significantly_increased	20	negative	7	7	CD		inactive	mild	response	partial_response	NA	NA	NA	non-SAE	none	none	no	none	none	NA	NA	no	L1
28_WL_3_ADA	28_WL_3_ADA	P28_ADA	35	F	17.8	underweight	non-smoker	IBD	CD	ADA	Hulio	7	28	no	none	EIM	first_biothrp	none	A2	B1	L1	non-L4	CD	EIM	joints	no_surgery	none	visit_3	2	week_8	8		25.04.2019	SC	40	5ASA	Pentasa	immunosupp	MTX	corticoids	Hydrokortizon	yes	Euthyrox_Calcichew_Omeprazol_Vigantol_Celecoxib_Doreta_folate	1	low	5.7	383	19.2	120	294	significantly_increased	20	negative	7	7	CD		inactive	mild	no_response	no_response	NA	NA	NA	non-SAE	none	none	no	none	none	NA	NA	no	L1
28_WL_4_ADA	28_WL_4_ADA	P28_ADA	35	F	17.8	underweight	non-smoker	IBD	CD	ADA	Hulio	7	28	no	none	EIM	first_biothrp	none	A2	B1	L1	non-L4	CD	EIM	joints	no_surgery	none	visit_4	3	week_14	14		06.06.2019	SC	40	5ASA	Pentasa	immunosupp	MTX	corticoids	Hydrokortizon	yes	Euthyrox_Calcichew_Omeprazol_Vigantol_Celecoxib_Doreta_folate	0.3	low	6.2	388	15.5	121	557	significantly_increased	20	negative	7	7	CD		inactive	mild	no_response	no_response	NA	NA	NA	non-SAE	none	none	no	none	"ADA_terminated,_switch_to_IFX"	withdrawal	end	no	L1
K3_M78_1	K3_M78_1	HC3	40	M	32	obesity	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K3_M78_2	K3_M78_2	HC3	40	M	32	obesity	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_2	1	week_2	2		HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K3_M78_3	K3_M78_3	HC3	40	M	32	obesity	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_3	2	week_26	26		HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K3_M78_4	K3_M78_4	HC3	40	M	32	obesity	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_4	3	week_28	28		HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K5_Z92_1	K5_Z92_1	HC5	27	F	30.9	obesity	smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K5_Z92_2	K5_Z92_2	HC5	27	F	30.9	obesity	smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_2	1	week_2	2		HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K5_Z92_3	K5_Z92_3	HC5	27	F	30.9	obesity	smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_3	2	week_26	26		HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K5_Z92_4	K5_Z92_4	HC5	27	F	30.9	obesity	smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_4	3	week_28	28		HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K18_Z93_1	K18_Z93_1	HC18	26	F	19.3	normal	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K18_Z93_2	K18_Z93_2	HC18	26	F	19.3	normal	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_2	1	week_2	2		HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K18_Z93_3	K18_Z93_3	HC18	26	F	19.3	normal	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_3	2	week_26	26		HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K18_Z93_4	K18_Z93_4	HC18	26	F	19.3	normal	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_4	3	week_28	28		HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K7_Z80_1	K7_Z80_1	HC7	35	M	20.1	normal	smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K7_Z80_2	K7_Z80_2	HC7	35	M	20.1	normal	smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_2	1	week_2	2		HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K7_Z80_3	K7_Z80_3	HC7	35	M	20.1	normal	smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_3	2	week_26	26		HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K7_Z80_4	K7_Z80_4	HC7	35	M	20.1	normal	smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_4	3	week_28	28		HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K16_Z75_1	K16_Z75_1	HC16	44	F	30.1	obesity	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K16_Z75_2	K16_Z75_2	HC16	44	F	30.1	obesity	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_2	1	week_2	2		HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K16_Z75_3	K16_Z75_3	HC16	44	F	30.1	obesity	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_3	2	week_26	26		HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K16_Z75_4	K16_Z75_4	HC16	44	F	30.1	obesity	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_4	3	week_28	28		HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K12_M78_1	K12_M78_1	HC12	41	M	25.5	overweight	smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K12_M78_2	K12_M78_2	HC12	41	M	25.5	overweight	smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_2	1	week_2	2		HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K12_M78_3	K12_M78_3	HC12	41	M	25.5	overweight	smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_3	2	week_26	26		HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K12_M78_4	K12_M78_4	HC12	41	M	25.5	overweight	smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_4	3	week_28	28		HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K6_M84_1	K6_M84_1	HC6	63	F	26.6	overweight	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K9_Z80_1	K9_Z80_1	HC9	39	F	21.8	normal	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K11_M87_1	K11_M87_1	HC11	31	M	20	normal	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K33_M78_1	K33_M78_1	HC33	41	M	25.2	overweight	smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K20_Z76_1	K20_Z76_1	HC20	42	F	27.3	overweight	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K31_Z80_1	K31_Z80_1	HC31	39	F	22.7	normal	smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	H	dry_peeling_skin_acne	no	none	none	NA	NA	no	HC
K15_Z77_1	K15_Z77_1	HC15	42	F	29.4	overweight	smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	lichen_ruben_planus_4_years_ago	no	none	none	NA	NA	no	HC
K8_Z79_1	K8_Z79_1	HC8	40	F	21.6	normal	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K34_Z96_1	K34_Z96_1	HC34	23	F	25.3	overweight	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K2_Z71_1	K2_Z71_1	HC2	48	F	33.5	obesity	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K4_Z79_1	K4_Z79_1	HC4	40	F	21.6	normal	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K37_Z82_1	K37_Z82_1	HC37	37	F	21.5	normal	smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K35_M99_1	K35_M99_1	HC35	20	M	20.3	normal	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K30_M95_1	K30_M95_1	HC30	24	M	19.9	normal	smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K41_Z90_1	K41_Z90_1	HC41	29	F	24.6	normal	smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K43_Z94_1	K43_Z94_1	HC43	25	F	18.5	normal	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K40_Z86_1	K40_Z86_1	HC40	33	F	25.6	overweight	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K25_Z91_1	K25_Z91_1	HC25	28	F	21.1	normal	non-smoker	HC	HC	HC	HC	HC	HC	no	none	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
29_MS_2	29_MS_2	P29	38	F	23.2	normal	smoker	IBD	CD	IFX	Remsima	12	26	no	none	perianal_disease	first_biothrp	none	A2	B3	L2	non-L4	CD	non-EIM	none	surgery	drainage	visit_2	1	week_2	2		15.04.2019	IV	5	no_5ASA	none	immunosupp	MTX	no_corticoids	none	yes	folate_Vigantol	2.8	low	6.2	182	150.94	132	36	normal	20	negative	3	3	CD		inactive	remission	response	partial_response	NA	NA	NA	non-SAE	none	none	no	none	none	NA	NA	no	L2
29_MS_3	29_MS_3	P29	38	F	23.2	normal	smoker	IBD	CD	IFX	Remsima	12	26	no	none	perianal_disease	first_biothrp	none	A2	B3	L2	non-L4	CD	non-EIM	none	surgery	drainage	visit_3	2	week_6	6		14.05.2019	IV	5	no_5ASA	none	immunosupp	MTX	no_corticoids	none	yes	folate_Vigantol	2.3	low	7.1	195	143.1	137	32	normal	20	negative	7	7	CD		inactive	mild	no_response	no_response	NA	NA	NA	non-SAE	none	none	no	none	none	NA	NA	no	L2
29_MS_4	29_MS_4	P29	38	F	23.2	normal	smoker	IBD	CD	IFX	Remsima	12	26	no	none	perianal_disease	first_biothrp	none	A2	B3	L2	non-L4	CD	non-EIM	none	surgery	drainage	visit_4	3	week_14	14		04.07.2019	IV	5	no_5ASA	none	immunosupp	MTX	no_corticoids	none	yes	folate_Vigantol	1.9	low	7	175	210.26	132	4	normal	20	negative	3	3	CD		inactive	remission	response	full_response	NA	NA	NA	non-SAE	none	none	no	none	none	NA	NA	no	L2
29_MS_5	29_MS_5	P29	38	F	23.2	normal	smoker	IBD	CD	IFX	Remsima	12	26	no	none	perianal_disease	first_biothrp	none	A2	B3	L2	non-L4	CD	non-EIM	none	surgery	drainage	visit_5	4	week_22	22		29.08.2019	IV	5	no_5ASA	none	immunosupp	MTX	no_corticoids	none	yes	folate_Vigantol	2.2	low	5.9	177	196.46	125	23	normal	8.4	negative	3	3	CD		inactive	remission	response	partial_response	NA	NA	NA	non-SAE	none	none	no	none	none	NA	NA	no	L2
29_MS_6	29_MS_6	P29	38	F	23.2	normal	smoker	IBD	CD	IFX	Remsima	12	26	no	none	perianal_disease	first_biothrp	none	A2	B3	L2	non-L4	CD	non-EIM	none	surgery	drainage	visit_7	6	week_30	30	0	24.10.2019	IV	5	no_5ASA	none	immunosupp	MTX	no_corticoids	none	yes	folate_Vigantol	2.5	low	6.4	176	223.9	127	23	normal	10.4	negative	4	4	CD		inactive	remission	response	partial_response	NA	NA	NA	non-SAE	none	none	no	none	none	NA	NA	no	L2
31_RK_1	31_RK_1	P31	33	F	18.6	normal	non-smoker	IBD	UC	ADA	Hulio	5	28	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	27.03.2019	SC	160	5ASA	Pentasa	no_immunosupp	none	corticoids	Medrol	yes	Caltrate_Kalnormin	0.7	low	11.1	269	55.61	154	455	significantly_increased	0	negative	UC		8	8	active	severe	baseline	baseline	responder	responder	baseline_response	non-SAE	none	none	no	none	none	start	start	no	E2
31_RK_2	31_RK_2	P31	33	F	19.7	normal	non-smoker	IBD	UC	ADA	Hulio	5	28	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_2	1	week_2	2		11.04.2019	SC	80	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	0.4	low	5.6	286	37.64	151	34	normal	18.9	negative	UC		1	1	inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E2
31_RK_3	31_RK_3	P31	33	F	19.7	normal	non-smoker	IBD	UC	ADA	Hulio	5	28	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_3	2	week_8	8		22.05.2019	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	0.3	low	9	288	37.13	146	6	normal	20	negative	UC		0	0	inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E2
31_RK_4	31_RK_4	P31	33	F	19.7	normal	non-smoker	IBD	UC	ADA	Hulio	5	28	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_4	3	week_14	14		04.07.2019	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	0.3	low	7.4	316	47.73	153	17	normal	20	negative	UC		0	0	inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E2
31_RK_5	31_RK_5	P31	33	F	19.7	normal	non-smoker	IBD	UC	ADA	Hulio	5	28	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_5	4	week_20	20	0	15.08.2019	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	0.3	low	7.4	316	47.73	153	22	normal	20	negative	UC		0	0	inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E2
31_RK_6	31_RK_6	P31	33	F	19.7	normal	non-smoker	IBD	UC	ADA	Hulio	5	28	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_6	5	week_26	26		26.09.2019	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	0.3	low	7.7	304	40.34	150	381	significantly_increased	20	negative	UC		0	0	inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E2
31_RK_7	31_RK_7	P31	33	F	19.7	normal	non-smoker	IBD	UC	ADA	Hulio	5	28	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_7	6	week_32	32		15.11.2019	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	0.3	low	9.4	266	35.21	157	21	normal	20	negative	UC		0	0	inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E2
31_RK_8	31_RK_8	P31	33	F	19.7	normal	non-smoker	IBD	UC	ADA	Hulio	5	28	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_8	7	week_38	38		17.01.2020	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	0.3	low	8.7	265	44.97	146	20	normal	19.7	negative	UC		0	0	inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	end	end	no	E2
32_RI_1	32_RI_1	P32	55	F	23.1	normal	non-smoker	IBD	CD	ADA	Hulio	5	50	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A3	B1	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_1	0	week_0	0	0	16.04.2019	SC	160	5ASA	Pentasa	no_immunosupp	none	corticoids	Medrol	yes	Calcichew_Helicid_Vigantol_Prestance	3	low	8.1	309	40.18	144	291	significantly_increased	0	negative	2	2	CD		inactive	remission	baseline	baseline	responder	responder	baseline_response	non-SAE	none	none	no	none	none	start	start	no	L3
32_RI_2	32_RI_2	P32	55	F	23.1	normal	non-smoker	IBD	CD	ADA	Hulio	5	50	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A3	B1	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_2	1	week_2	2		30.04.2019	SC	80	5ASA	Pentasa	no_immunosupp	none	corticoids	Medrol	yes	Calcichew_Helicid_Vigantol_Prestance	0.5	low	7.8	315	40.6	138	240	significantly_increased	20	positive	2	2	CD		inactive	remission	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
32_RI_3	32_RI_3	P32	55	F	23.1	normal	non-smoker	IBD	CD	ADA	Hulio	5	50	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A3	B1	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_3	2	week_8	8		11.06.2019	SC	40	no_5ASA	none	no_immunosupp	none	corticoids	Medrol	yes	Calcichew_Helicid_Vigantol_Prestance	1.7	low	6.6	302	61.89	143		NA	20	positive	4	4	CD		inactive	remission	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
32_RI_5	32_RI_5	P32	55	F	22.7	normal	non-smoker	IBD	CD	ADA	Hulio	5	50	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A3	B1	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_5	4	week_20	20	0	05.09.2019	SC	40	no_5ASA	none	no_immunosupp	none	corticoids	Hydrokortizon	yes	Calcichew_Helicid_Vigantol_Prestance	2	low	8	295	28.53	140	46	normal	15	positive	3	3	CD		inactive	remission	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
32_RI_7	32_RI_7	P32	55	F	23.1	normal	non-smoker	IBD	CD	ADA	Hulio	5	50	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A3	B1	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_7	6	week_32	32		26.11.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Calcichew_Helicid_Vigantol_Prestance_Sulfasalazin	1.3	low	7.5	298	67.3	140	34	normal	16.5	negative	2	2	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	end	end	no	L3
32_RI_4	32_RI_4	P32	55	F	22.7	normal	non-smoker	IBD	CD	ADA	Hulio	5	50	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A3	B1	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_4	3	week_14	14		18.07.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Calcichew_Helicid_Vigantol_Prestance	1.3	low	7.8	308	58.34	145	118	slightly_increased	20	negative	3	3	CD		inactive	remission	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
45_SK_1	45_SK_1	P45	25	F	19.2	normal	non-smoker	IBD	CD	ADA	Hulio	4	21	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	EIM	joints	no_surgery	none	visit_1	0	week_0	0	0	18.07.2019	SC	160	5ASA	Pentasa	no_immunosupp	none	corticoids	Prednison	yes	Apo-panto	0.4	low	8.1	290	35.3	141	120	slightly_increased	0	negative	3	3	CD		inactive	remission	baseline	baseline	NA	NA	NA	SAE	none	none	yes	herpes	herpes_terminated_due_to_infection_complications	NA	NA	no	L1
48_LL_1	48_LL_1	P48	28	F	20	normal	non-smoker	IBD	UC	IFX	Remsima	13	12	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A1	UC	UC	UC	E3	EIM	joints	no_surgery	none	visit_1	0	week_0	0	0	06.08.2019	IV	5	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	yes	Sulfasalazin	0.5	low	4.9	477	1.92	96	221	significantly_increased	0	negative	UC		5	5	active	moderate	baseline	baseline	NA	NA	NA	non-SAE	none	none	no	none	none	start	start	no	E3
48_LL_2	48_LL_2	P48	28	F	20	normal	non-smoker	IBD	UC	IFX	Remsima	13	12	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A1	UC	UC	UC	E3	EIM	joints	no_surgery	none	visit_2	1	week_2	2		20.08.2020	IV	5	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	yes	Sulfasalazin	0.2	low	4.4	376	77.88	109	432	significantly_increased	20	negative	UC		5	5	active	moderate	no_response	no_response	NA	NA	NA	non-SAE	none	none	no	none	none	NA	NA	no	E3
48_LL_4	48_LL_4	P48	28	F	19.6	normal	non-smoker	IBD	UC	IFX	Remsima	13	12	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A1	UC	UC	UC	E3	EIM	joints	no_surgery	none	visit_4	3	week_14	14		12.11.2019	IV	10	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	yes	Sulfasalazin	0.8	low	6.6	369	6.62	137	840	significantly_increased	5.9	negative	UC		7	7	active	moderate	response	partial_response	NA	NA	NA	non-SAE	none	none	no	none	none	NA	NA	no	E3
48_LL_5	48_LL_5	P48	28	F	20.3	normal	non-smoker	IBD	UC	IFX	Remsima	13	12	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A1	UC	UC	UC	E3	EIM	joints	no_surgery	none	visit_5	4	week_22	22		24.01.2020	IV	10	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	yes	Sulfasalazin	0.2	low	4.5	299	2.79	125	130	slightly_increased	8.9	negative	UC		1	1	inactive	remission	response	full_response	NA	NA	NA	non-SAE	none	none	no	none	none	NA	NA	no	E3
48_LL_6	48_LL_6	P48	28	F	20.3	normal	non-smoker	IBD	UC	IFX	Remsima	13	12	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A1	UC	UC	UC	E3	EIM	joints	no_surgery	none	visit_7	6	week_30	30	0	04.03.2020	IV	10	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	0.5	low	6.7	339	6.45	137	720	significantly_increased	11.9	negative	UC		9	9	active	severe	no_response	no_response	NA	NA	NA	non-SAE	none	none	no	none	none	end	end	no	E3
P49_LT_1	P49_LT_1	P49	29	F	18.5	normal	non-smoker	IBD	UC	IFX	Remsima	1	28	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	14.08.2019	IV	5	no_5ASA	none	immunosupp	AZA	corticoids	Prednison	yes	KCl_Caltrate_Contoloc_Magnosolv_Budenofalk_Sumatriptan	49.5	high	10.9	269	13.94	104	332	significantly_increased	0	negative	UC		9	9	active	severe	baseline	baseline	partial-responder	responder	baseline_partial_response	non-SAE	none	none	no	none	none	start	start	no	E2
P49_LT_2	P49_LT_2	P49	29	F	18.5	normal	non-smoker	IBD	UC	IFX	Remsima	1	28	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_2	1	week_2	2		26.08.2019	IV	5	no_5ASA	none	immunosupp	AZA	corticoids	Prednison	yes	KCl_Caltrate_Contoloc_Magnosolv_Budenofalk_Sumatriptan	12.8	high	10.7	298	6.24	90	6000	significantly_increased	9.5	negative	UC		5	5	active	moderate	response	full_response	partial-responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E2
P49_LT_3	P49_LT_3	P49	29	F	19.2	normal	non-smoker	IBD	UC	IFX	Remsima	1	28	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_3	2	week_6	6		25.09.2019	IV	5	no_5ASA	none	immunosupp	AZA	corticoids	Prednison	yes	KCl_Caltrate_Contoloc_Eliquis_Sumatriptan	7.4	low	8.7	348	36.06	114	3622	significantly_increased	4.2	negative	UC		5	5	active	moderate	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	E2
P49_LT_4	P49_LT_4	P49	29	F	20	normal	non-smoker	IBD	UC	IFX	Remsima	1	28	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_4	3	week_14	14		06.11.2019	IV	10	no_5ASA	none	immunosupp	AZA	corticoids	Prednison	yes	KCl_Caltrate_Contoloc_Sumatriptan_Eliquis	0.3	low	6	287	4.06	118	308	significantly_increased	5.3	negative	UC		3	3	inactive	mild	response	full_response	partial-responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E2
P49_LT_6	P49_LT_6	P49	29	F	20	normal	non-smoker	IBD	UC	IFX	Remsima	1	28	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_7	6	week_30	30	0	12.02.2020	IV	5	no_5ASA	none	immunosupp	AZA	corticoids	Prednison	yes	Eliquis_Sumatriptan	0.8	low	5.9	334	4.79	118	341	significantly_increased	16.9	negative	UC		3	3	inactive	mild	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	E2
P49_LT_7	P49_LT_7	P49	29	F	20	normal	non-smoker	IBD	UC	IFX	Remsima	1	28	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_8	7	week_38	38		13.05.2020	IV	5	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Sumatriptan	1.2	low	4.4	307	8.15	123	229	significantly_increased	5.5	negative	UC		4	4	inactive	mild	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	end	end	no	E2
P52_KB_1	P52_KB_1	P52	47	M	27.1	overweight	smoker	IBD	CD	ADA	Hulio	3	44	yes	polio	conventional_therapy_ineffectiveness	first_biothrp	none	A3	B1	L2	non-L4	CD	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	21.08.2019	SC	160	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	5.7	low	8.5	275	40.6	148	947	significantly_increased	0	negative	3	3	CD		inactive	remission	baseline	baseline	responder	responder	baseline_response	non-SAE	none	none	no	none	none	start	start	no	L2
P52_KB_2	P52_KB_2	P52	47	M	27.1	overweight	smoker	IBD	CD	ADA	Hulio	3	44	yes	polio	conventional_therapy_ineffectiveness	first_biothrp	none	A3	B1	L2	non-L4	CD	non-EIM	none	no_surgery	none	visit_2	1	week_2	2		04.09.2019	SC	80	no_5ASA	none	no_immunosupp	none	no_corticoids	none	no	none	2.5	low	7.2	253	65.66	162	21	normal	14.6	positive	1	1	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L2
P52_KB_3	P52_KB_3	P52	47	M	27.1	overweight	smoker	IBD	CD	ADA	Hulio	3	44	yes	polio	conventional_therapy_ineffectiveness	first_biothrp	none	A3	B1	L2	non-L4	CD	non-EIM	none	no_surgery	none	visit_3	2	week_8	8		02.10.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	no	none	2.4	low	5.9	256	66.21	149	14	normal	16.7	negative	2	2	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L2
P52_KB_4	P52_KB_4	P52	47	M	27.1	overweight	smoker	IBD	CD	ADA	Hulio	3	44	yes	polio	conventional_therapy_ineffectiveness	first_biothrp	none	A3	B1	L2	non-L4	CD	non-EIM	none	no_surgery	none	visit_4	3	week_14	14		26.11.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	no	none	4	low	5.3	202	82.07	158	20	normal	12.1	negative	1	1	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L2
P52_KB_5	P52_KB_5	P52	47	M	27.1	overweight	smoker	IBD	CD	ADA	Hulio	3	44	yes	polio	conventional_therapy_ineffectiveness	first_biothrp	none	A3	B1	L2	non-L4	CD	non-EIM	none	no_surgery	none	visit_5	4	week_20	20	0	10.01.2020	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	no	none	3.3	low	6.1	206	144.02	154	17	normal	10.1	negative	2	2	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L2
P52_KB_8	P52_KB_8	P52	47	M	27.5	overweight	smoker	IBD	CD	ADA	Hulio	3	44	yes	polio	conventional_therapy_ineffectiveness	first_biothrp	none	A3	B1	L2	non-L4	CD	non-EIM	none	no_surgery	none	visit_8	7	week_38	38		26.06.2020	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	no	none	5.7	low	4.9	215	121	143	80	slightly_increased	0.7	positive	1	1	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	end	end	no	L2
P53_CZ_1	P53_CZ_1	P53	41	F	29.7	overweight	smoker	IBD	CD	IFX	Remsima	2	39	no	none	perianal_disease	first_biothrp	none	A2	B3	L1	non-L4	CD	non-EIM	none	surgery	drainage	visit_1	0	week_0	0	0	28.08.2019	IV	5	no_5ASA	none	no_immunosupp	none	corticoids	Budesonid	yes	Omeprazol	2.4	low	13.3	243	10.15	136	117	slightly_increased	0	negative	3	3	CD		inactive	remission	baseline	baseline	partial-responder	responder	baseline_partial_response	non-SAE	none	none	no	none	none	start	start	no	L1
P53_CZ_2	P53_CZ_2	P53	41	F	29.3	overweight	smoker	IBD	CD	IFX	Remsima	2	39	no	none	perianal_disease	first_biothrp	none	A2	B3	L1	non-L4	CD	non-EIM	none	surgery	drainage	visit_2	1	week_2	2		11.09.2019	IV	5	no_5ASA	none	no_immunosupp	none	corticoids	Budesonid	yes	Omeprazol	5.8	low	8.3	216	11.89	134	122	slightly_increased	19.7	positive	3	3	CD		inactive	remission	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P53_IS_CZ_3	P53_IS_CZ_3	P53	41	F	29.3	overweight	smoker	IBD	CD	IFX	Remsima	2	39	no	none	perianal_disease	first_biothrp	none	A2	B3	L1	non-L4	CD	non-EIM	none	surgery	drainage	visit_3	2	week_6	6		08.10.2019	IV	5	no_5ASA	none	no_immunosupp	none	corticoids	Budesonid	yes	Omeprazol_Caltrate	3	low	10.7	255	7.3	130	81	slightly_increased	2.9	positive	7	7	CD		inactive	mild	no_response	no_response	partial-responder	responder	no_response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P53_CZ_4	P53_CZ_4	P53	41	F	29.3	overweight	smoker	IBD	CD	IFX	Remsima	2	39	no	none	perianal_disease	first_biothrp	none	A2	B3	L1	non-L4	CD	non-EIM	none	surgery	drainage	visit_4	3	week_14	14		04.12.2019	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Omeprazol_Caltrate	1.3	low	10.2	241	9.45	132	177	slightly_increased	1.6	positive	6	6	CD		inactive	mild	response	partial_response	partial-responder	responder	partial_response	SAE	"A,D,F"	none	no	none	none	NA	NA	no	L1
P53_CZ_5	P53_CZ_5	P53	41	F	29.3	overweight	smoker	IBD	CD	IFX	Remsima	2	39	no	none	perianal_disease	first_biothrp	none	A2	B3	L1	non-L4	CD	non-EIM	none	surgery	drainage	visit_5	4	week_22	22		20.02.2020	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Omeprazol_Caltrate	5	low	8.9	242	10.41	131	82	slightly_increased	0.1	negative	4	4	CD		inactive	remission	response	partial_response	partial-responder	responder	partial_response	SAE	"A,D,F"	none	no	none	none	NA	NA	no	L1
P53_CZ_7	P53_CZ_7	P53	41	F	28.9	overweight	smoker	IBD	CD	IFX	Remsima	2	39	no	none	perianal_disease	first_biothrp	none	A2	B3	L1	non-L4	CD	non-EIM	none	surgery	drainage	visit_8	7	week_38	38		10.06.2020	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Omeprazol_Caltarte_Plaquenil	6.9	low	8.6	234	10	138	227	significantly_increased	1.7	positive	6	6	CD		inactive	mild	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P56_SP_1	P56_SP_1	P56	22	F	20.8	normal	non-smoker	IBD	UC	IFX	Remsima	1	20	yes	hypothyroidism	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	09.09.2019	IV	5	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Letrox	4.4	low	5.3	240	5.04	100	2654	significantly_increased	0	negative	UC		7	7	active	moderate	baseline	baseline	partial-responder	responder	baseline_partial_response	non-SAE	none	none	no	none	none	start	start	no	E3
P56_SP_2	P56_SP_2	P56	22	F	20.8	normal	non-smoker	IBD	UC	IFX	Remsima	1	20	yes	hypothyroidism	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_2	1	week_2	2		25.09.2019	IV	5	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Letrox	1	low	5.6	288	6.91	99	814	significantly_increased	20	negative	UC		3	3	inactive	mild	response	full_response	partial-responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E3
P56_SP_3	P56_SP_3	P56	22	F	20.8	normal	non-smoker	IBD	UC	IFX	Remsima	1	20	yes	hypothyroidism	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_3	2	week_6	6		24.10.2019	IV	5	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Letrox	0.7	low	5	309	2.26	95	2855	significantly_increased	20	negative	UC		4	4	inactive	mild	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	E3
P56_SP_6	P56_SP_6	P56	22	F	20.8	normal	non-smoker	IBD	UC	IFX	Remsima	1	20	yes	hypothyroidism	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_7	6	week_30	30	0	07.04.2020	IV	7	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Letrox	1.6	low	9	271	4.73	119	1900	significantly_increased	3.8	negative	UC		4	4	inactive	mild	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	E3
P56_SP_5	P56_SP_5	P56	22	F	20.8	normal	non-smoker	IBD	UC	IFX	Remsima	1	20	yes	hypothyroidism	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_5	4	week_22	22		11.02.2020	IV	5	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Letrox	1.3	low	5.9	299	9.99	119	2411	significantly_increased	8	negative	UC		6	6	active	moderate	no_response	no_response	partial-responder	responder	no_response	non-SAE	none	none	no	none	none	NA	NA	no	E3
P56_SP_7	P56_SP_7	P56	22	F	20.8	normal	non-smoker	IBD	UC	IFX	Remsima	1	20	yes	hypothyroidism	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_8	7	week_38	38		01.06.2020	IV	7	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Letrox	0.6	low	6	309	3	104	1805	significantly_increased	10.3	negative	UC		5	5	active	moderate	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	end	end	no	E3
P50_SMN_1	P50_SMN_1	P50	23	F	19.4	normal	non-smoker	IBD	UC	ADA	Imraldi	4	19	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E1	EIM	hidradenitis_suppurativa	no_surgery	none	visit_1	0	week_0	0	0	15.08.2019	SC	160	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	1	low	6.3	295	29.13	123	3562	significantly_increased	0	negative	UC		4	4	inactive	mild	baseline	baseline	responder	responder	baseline_response	non-SAE	none	none	no	none	none	start	start	no	E1
P50_SMN_2	P50_SMN_2	P50	23	F	19.4	normal	non-smoker	IBD	UC	ADA	Imraldi	4	19	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E1	EIM	hidradenitis_suppurativa	no_surgery	none	visit_2	1	week_2	2		29.08.2019	SC	80	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	0.4	low	7.8	281	19.42	129	181	slightly_increased	17.2	negative	UC		3	3	inactive	mild	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	E1
P50_SMN_3	P50_SMN_3	P50	23	F	20	normal	non-smoker	IBD	UC	ADA	Imraldi	4	19	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E1	EIM	hidradenitis_suppurativa	no_surgery	none	visit_3	2	week_8	8		10.10.2019	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	yes	Doxycyklin	0.8	low	5.4	306	15.87	135	6000	significantly_increased	20	negative	UC		1	1	inactive	remission	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	E1
P50_SMN_4	P50_SMN_4	P50	23	F	20	normal	non-smoker	IBD	UC	ADA	Imraldi	4	19	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E1	EIM	hidradenitis_suppurativa	no_surgery	none	visit_4	3	week_14	14		20.11.2019	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	0.5	low	6.1	311	14.24	131	3735	significantly_increased	17.8	negative	UC		1	1	inactive	remission	response	partial_response	responder	responder	partial_response	SAE	none	none	no	none	2times_ataka_herpes	NA	NA	no	E1
P50_SMN_5	P50_SMN_5	P50	23	F	20	normal	non-smoker	IBD	UC	ADA	Imraldi	4	19	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E1	EIM	hidradenitis_suppurativa	no_surgery	none	visit_5	4	week_20	20	0	08.01.2020	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	yes	Herpesin	2.1	low	6	312	26.99	128	3077	significantly_increased	20	negative	UC		0	0	inactive	remission	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	E1
P50_SMN_6	P50_SMN_6	P50	23	F	20	normal	non-smoker	IBD	UC	ADA	Imraldi	4	19	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E1	EIM	hidradenitis_suppurativa	no_surgery	none	visit_6	5	week_26	26		20.02.2020	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	0.6	low	4.5	295	22.93	127	6000	significantly_increased	20	negative	UC		0	0	inactive	remission	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	E1
P50_SMN_8	P50_SMN_8	P50	23	F	20	normal	non-smoker	IBD	UC	ADA	Imraldi	4	19	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E1	EIM	hidradenitis_suppurativa	no_surgery	none	visit_8	7	week_38	38		14.05.2020	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	1	low	6.2	291	18.63	132	494	significantly_increased	20	negative	UC		1	1	inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	end	end	no	E1
P65_KS_1	P65_KS_1	P65	48	F	36.8	obesity	non-smoker	IBD	UC	IFX	Remsima	6	42	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	26.09.2019	IV	5	no_5ASA	none	no_immunosupp	none	corticoids	Prednison	yes	Salofalk_supp_metro+ped_supp_Calcichew_Cipralex	0.7	low	7.1	282	26.95	138	534	significantly_increased	0	negative	UC		7	7	active	moderate	baseline	baseline	responder	responder	baseline_response	non-SAE	none	none	no	none	none	start	start	no	E3
P65_KS_2	P65_KS_2	P65	48	F	36.8	obesity	non-smoker	IBD	UC	IFX	Remsima	6	42	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_2	1	week_2	2		08.10.2019	IV	5	no_5ASA	none	no_immunosupp	none	corticoids	Prednison	yes	Salofalk_supp_Calcichew_Cipralex	0.3	low	6.5	241	21.6	145	82	slightly_increased	20	negative	UC		6	6	active	moderate	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	E3
P65_KS_3	P65_KS_3	P65	48	F	36.8	obesity	non-smoker	IBD	UC	IFX	Remsima	6	42	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_3	2	week_6	6		05.11.2019	IV	5	no_5ASA	none	no_immunosupp	none	corticoids	Prednison	yes	Salofalk_supp_Calcichew_Cipralex	0.8	low	7.8	252	19.76	137	111	slightly_increased	20	negative	UC		6	6	active	moderate	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E3
P65_KS_4	P65_KS_4	P65	48	F	36.8	obesity	non-smoker	IBD	UC	IFX	Remsima	6	42	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_4	3	week_14	14		10.12.2019	IV	5	no_5ASA	none	no_immunosupp	none	corticoids	Hydrokortizon	yes	Salofalk_supp_Calcichew_Cipralex	0.9	low	5.8	255	16.82	142	17	normal	20	negative	UC		0	0	inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E3
P65_KS_5	P65_KS_5	P65	48	F	39	obesity	non-smoker	IBD	UC	IFX	Remsima	6	42	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_5	4	week_22	22		25.02.2020	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Calcichew_Cipralex	0.8	low	5.7	265	27.15	138	10	normal	20	negative	UC		3	3	active	moderate	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	E3
P66_CR_1	P66_CR_1	P66	31	M	23.7	normal	non-smoker	IBD	CD	IFX	Remsima	4	27	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	26.09.2019	IV	5	no_5ASA	none	immunosupp	MTX	no_corticoids	none	yes	Caltrate_folate_Vigantol	2.8	low	4.4	196	85.65	163	97	slightly_increased	0	negative	0	0	CD		inactive	remission	baseline	baseline	responder	responder	baseline_response	non-SAE	none	none	no	none	none	start	start	no	L1
P66_CR_3	P66_CR_3	P66	31	M	23.7	normal	non-smoker	IBD	CD	IFX	Remsima	4	27	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_3	2	week_6	6		07.11.2019	IV	5	no_5ASA	none	immunosupp	MTX	no_corticoids	none	yes	Caltrate_folate_Vigantol	0.7	low	4.6	178	66.21	161	37	normal	20	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P66_CR_4	P66_CR_4	P66	31	M	24	normal	non-smoker	IBD	CD	IFX	Remsima	4	27	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_4	3	week_14	14		06.01.2020	IV	5	no_5ASA	none	immunosupp	MTX	no_corticoids	none	yes	Caltrate_folate_Vigantol	0.8	low	5	177	74.35	162	25	normal	5.8	negative	1	1	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P66_CR_5	P66_CR_5	P66	31	M	24	normal	non-smoker	IBD	CD	IFX	Remsima	4	27	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_5	4	week_22	22		02.03.2020	IV	5	no_5ASA	none	immunosupp	MTX	no_corticoids	none	yes	Caltrate_folate_Vigantol	0.6	low	3.6	192	116.71	168	23	normal	7.4	negative	1	1	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P66_CR7	P66_CR7	P66	31	M	24	normal	non-smoker	IBD	CD	IFX	Remsima	4	27	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_8	7	week_38	38		25.06.2020	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Caltrate_Vigantol	0.8	low	5.5	202	85	170	40	normal		NA	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	end	end	no	L1
P71_SJ_1	P71_SJ_1	P71	29	F	24	normal	non-smoker	IBD	CD	ADA	Imraldi	3	26	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	30.10.2019	SC	160	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	0.6	low	6	384	137.14	112	241	significantly_increased	0	negative	7	7	CD		inactive	mild	baseline	baseline	partial-responder	responder	baseline_partial_response	non-SAE	none	none	no	none	none	start	start	no	L1
P71_SJ_2	P71_SJ_2	P71	29	F	24	normal	non-smoker	IBD	CD	ADA	Imraldi	3	26	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_2	1	week_2	2		13.11.2019	SC	80	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	0.7	low	4.4	337	88.22	116	149	slightly_increased	16.2	negative	5	5	CD		inactive	mild	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P71_SJ_3	P71_SJ_3	P71	29	F	24	normal	non-smoker	IBD	CD	ADA	Imraldi	3	26	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_3	2	week_8	8		13.12.2019	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none		NA					54	slightly_increased		NA	4	4	CD		inactive	remission	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P71_SJ_4	P71_SJ_4	P71	29	F	24	normal	non-smoker	IBD	CD	ADA	Imraldi	3	26	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_4	3	week_14	14		05.02.2020	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	0.4	low	5.5	309	17.96	131	108	slightly_increased	20	negative	5	5	CD		inactive	mild	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P60_KM_1	P60_KM_1	P60	30	M	23.4	normal	non-smoker	IBD	CD	IFX	Remsima	14	16	no	none	perianal_and_terminal_ileum_infliction	repet_biothrp	ADA	A1	B3	L3	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_extra		week_x			20.09.2019	IV	5	no_5ASA	none	immunosupp	yes	no_corticoids	none	no	none	5.6	low	6.3	303	46.98	155	462	significantly_increased	2.6	negative	2	2	CD		inactive	remission	response	partial_response	NA	NA	NA	SAE	D	none	yes	foreskin	"skin_manifestations_on_the_face,eczema,balanitis_repeatedly"	NA	NA	SAE_only	L3
P79_MM_1	P79_MM_1	P79	45	M	22.2	normal	smoker	IBD	CD	IFX	Remsima	18	27	no	none	luminal_infliction	first_biothrp	none	A2	B2	L3	non-L4	CD	non-EIM	none	no_surgery	none	visit_extra		week_x			09.12.2019	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	no	none	0.5	low	10.6	296	75.23	177	30	normal	8.8	negative	3	3	CD		inactive	remission	response	full_response	NA	NA	NA	SAE	none	none	no	none	"skin_scaling_erytematose_deposit_painless_lower_abdomen_and_penis_root,_edemaless,_painless,_itchyless"	NA	NA	SAE_only	L3
P80_KA_1	P80_KA_1	P80	43	F	33.1	obesity	non-smoker	IBD	CD	IFX	Remsima	1	43	yes	thyroid_cancer_strumectomy	perianal_disease	first_biothrp	none	A2	B3	L3	non-L4	CD	EIM	joints	surgery	drainage	visit_1	0	week_0	0	0	21.02.2020	IV	5	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Pantoprazol_Letrox	12.6	high	8.5	442	35.1	143	63	slightly_increased	0	negative	8	8	CD		active	moderate	baseline	baseline	NA	NA	NA	non-SAE	none	none	no	none	none	start	start	no	L3
P80_KA_2	P80_KA_2	P80	43	F	33.1	obesity	non-smoker	IBD	CD	IFX	Remsima	1	43	yes	thyroid_cancer_strumectomy	perianal_disease	first_biothrp	none	A2	B3	L3	non-L4	CD	EIM	joints	surgery	drainage	visit_2	1	week_2	2		03.02.2020	IV	5	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Metro_+_before_supp_Pantoprazol_Letrox_Calcichew_Vigantol	5.8	low	9.8	409	16.64	136	12	normal	18.9	negative	10	10	CD		active	moderate	no_response	no_response	NA	NA	NA	non-SAE	none	none	no	none	none	NA	NA	no	L3
P80_KA_3	P80_KA_3	P80	43	F	33.1	obesity	non-smoker	IBD	CD	IFX	Remsima	1	43	yes	thyroid_cancer_strumectomy	perianal_disease	first_biothrp	none	A2	B3	L3	non-L4	CD	EIM	joints	surgery	drainage	visit_3	2	week_6	6		02.03.2020	IV	5	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Metro_+_before_supp_Pantoprazol_Letrox_Calcichew_Vigantol	6.5	low	9.7	402	16.03	143	9	normal	10.6	negative	2	2	CD		inactive	remission	response	partial_response	NA	NA	NA	SAE	"A,B"	none	no	none	"paradoxical_psoriasis,_no_swabs_available"	withdrawal	end	no	L3
P59_NP_1	P59_NP_1	P59	33	M	26.8	overweight	non-smoker	IBD	CD	IFX	Remsima	6	27	no	none	luminal_infliction	first_biothrp	none	A2	B2	L3	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_extra		week_x			18.09.2019	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	no	none	0.7	low	7.6	228	131.25	155		NA	11.2	negative	0	0	CD		inactive	remission	response	full_response	NA	NA	NA	SAE	none	none	yes	navel	"navel_scaling_deposit_,_itchy,local_therapy_from_skin_amb_without_big_effectu,_this_cca_1year"	NA	NA	SAE_only	L3
K39_1	K39_1	HC39	22	F	22.9	normal	smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	08.07.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
46_TT_1	46_TT_1	P46	26	M	17.8	underweight	non-smoker	IBD	UC	IFX	Remsima	3	23	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	19.07.2019	IV	5	5ASA	Asacol	immunosupp	AZA	no_corticoids	none	no	none	9.2	low	10.6	306	114.43	146	2497	significantly_increased	0	negative	UC		8	8	active	severe	baseline	baseline	NA	NA	NA	non-SAE	none	none	no	none	none	start	start	no	E2
46_TT_2	46_TT_2	P46	26	M	17.8	underweight	non-smoker	IBD	UC	IFX	Remsima	3	23	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_2	1	week_2	2		01.08.2019	IV	5	5ASA	Asacol	immunosupp	AZA	no_corticoids	none	no	none	3.8	low	4.9	293	98.1	136	143	slightly_increased	20	negative	UC		10	10	active	severe	no_response	no_response	NA	NA	NA	non-SAE	none	none	no	none	none	NA	NA	no	E2
46_TT_3	46_TT_3	P46	26	M	17.8	underweight	non-smoker	IBD	UC	IFX	Remsima	3	23	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E2	non-EIM	none	no_surgery	none	visit_3	2	week_8	8		28.08.2019	NA	5	5ASA	Asacol	immunosupp	AZA	no_corticoids	none	no	none		NA						NA		NA	UC		10	10	active	severe	no_response	no_response	NA	NA	NA	non-SAE	none	none	no	none	started_Entyvio(alpha4beta7integrin)	withdrawal	end	no	E2
21_PP_7_IFX_1_ADA	21_PP_7_IFX_1_ADA	P21_ADA	25	F	22	normal	smoker	IBD	CD	ADA	Hulio	2	23	no	none	intensified_IFX_ineffectiveness_switch_without_washout	repet_biothrp	IFX	A2	B3	L3	non-L4	CD	EIM	joints	surgery	drainage	visit_1	0	week_0	0	0	14.11.2019	SC	160	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Emanera_Calcichew	7.8	low	7.2	412	31.17	137	222	significantly_increased	0	negative	1	1	CD		inactive	remission	baseline	baseline	partial-responder	responder	baseline_partial_response	non-SAE	none	none	no	none	none	start	start	no	L3
21_PP_2_ADA	21_PP_2_ADA	P21_ADA	25	F	22	normal	smoker	IBD	CD	ADA	Hulio	2	23	no	none	intensified_IFX_ineffectiveness_switch_without_washout	repet_biothrp	IFX	A2	B3	L3	non-L4	CD	EIM	joints	surgery	drainage	visit_2	1	week_2	2		04.12.2019	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Emanera_Calcichew	7.8	low	9.6	353	32.24	127		NA	20	negative	1	1	CD		inactive	remission	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
mock_2_DNA	mock_2_DNA	NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA						NA		NA	NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	no	NA
mock_2_bact	mock_2_bact	NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA						NA		NA	NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	no	NA
21_PP_3_ADA	21_PP_3_ADA	P21_ADA	25	F	22	normal	smoker	IBD	CD	ADA	Hulio	2	23	no	none	intensified_IFX_ineffectiveness_switch_without_washout	repet_biothrp	IFX	A2	B3	L3	non-L4	CD	EIM	joints	surgery	drainage	visit_3	2	week_8	8		23.01.2020	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Emanera_Calcichew	5.2	low	10.4	358	43.76	128	287	significantly_increased	20	negative	3	3	CD		inactive	remission	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
21_PP_4_ADA	21_PP_4_ADA	P21_ADA	25	F	22.8	normal	smoker	IBD	CD	ADA	Hulio	2	23	no	none	intensified_IFX_ineffectiveness_switch_without_washout	repet_biothrp	IFX	A2	B3	L3	non-L4	CD	EIM	joints	surgery	drainage	visit_4	3	week_14	14		05.03.2020	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Emanera_Calcichew	5.9	low	9.2	368	32.14	141	281	significantly_increased	20	negative	3	3	CD		inactive	remission	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
29_MS_7	29_MS_7	P29	38	F	23.2	normal	smoker	IBD	CD	IFX	Remsima	12	26	no	none	perianal_disease	first_biothrp	none	A2	B3	L2	non-L4	CD	non-EIM	none	surgery	drainage	visit_8	7	week_38	38		12.12.2019	IV	5	no_5ASA	none	immunosupp	MTX	no_corticoids	none	yes	ac.folicum_Vigantol	1.1	low	4.9	178	178.05	130	33	normal	6.7	negative	0	0	CD		inactive	remission	response	full_response	NA	NA	NA	non-SAE	none	none	no	none	none	NA	NA	no	L2
P65_KS_7	P65_KS_7	P65	48	F	39	obesity	non-smoker	IBD	UC	IFX	Remsima	6	42	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_8	7	week_38	38		16.06.2020	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Calcichew_Cipralex_Detralex	0.5	low	6.1	278	29	136	20	normal	13.7	negative	UC		0	0	inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	end	end	no	E3
P71_SJ_8	P71_SJ_8	P71	29	F	24	normal	non-smoker	IBD	CD	ADA	Imraldi	3	26	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_8	7	week_38	38		15.07.2020	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	0.5	low	5.3	470	2	96	388	significantly_increased	11.8	negative	5	5	CD		inactive	mild	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	end	end	no	L1
21_PP_7_ADA	21_PP_7_ADA	P21_ADA	25	F	23.5	normal	smoker	IBD	CD	ADA	Hulio	2	23	no	none	intensified_IFX_ineffectiveness_switch_without_washout	repet_biothrp	IFX	A2	B3	L3	non-L4	CD	EIM	joints	surgery	drainage	visit_7	6	week_32	32		27.08.2020	NA	NA	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Emanera_Calcichew_HAK	5.1	low	7.7	336	45	130	249	significantly_increased	5.4	negative	5	5	CD		inactive	mild	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	"rhinitis_since_March_2020_green_purulent_secretion,_corticoids_after_prescribed_PL,_then_ATB_nasal_drops_-_all_without_effect,_afterwards_allergological_examination_-_allergy_excluded_(blood_and_skin_pinprick_tests)_Last_week_dry_cough_without_expectoration_or_fever_Last_three_weeks_herpes,_now_ragads,_prolonged_wound_healing,_gingivitis_has_subsided"	end	end	no	L3
21_PP_5_ADA	21_PP_5_ADA	P21_ADA	25	F	22.8	normal	smoker	IBD	CD	ADA	Hulio	2	23	no	none	intensified_IFX_ineffectiveness_switch_without_washout	repet_biothrp	IFX	A2	B3	L3	non-L4	CD	EIM	joints	surgery	drainage	visit_5	4	week_20	20	0	16.04.2020	SC	40	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Emanera_Calcichew	6.8	low	7.6	310	25.08	131	194	slightly_increased	20	negative	3	3	CD		inactive	remission	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
P72_DM_1	P72_DM_1	P72	34	F	18.6	normal	non-smoker	IBD	CD	IFX	Remsima	3	31	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L1	L4	CD	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	12.11.2019	IV	5	no_5ASA	none	immunosupp	AZA	corticoids	Budesonid	yes	Caltrate	94.6	high	3.5	494	173.76	120	2160	significantly_increased	0	negative	4	4	CD		inactive	remission	baseline	baseline	responder	responder	baseline_response	non-SAE	none	none	no	none	none	start	start	no	L1
P72_DM_2	P72_DM_2	P72	34	F	18.6	normal	non-smoker	IBD	CD	IFX	Remsima	3	31	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L1	L4	CD	non-EIM	none	no_surgery	none	visit_2	1	week_2	2		26.11.2019	IV	5	no_5ASA	none	immunosupp	AZA	corticoids	Budesonid	yes	Caltarte	2.5	low	4.5	452	88.33	131	181	slightly_increased	6.9	negative	3	3	CD		inactive	remission	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P72_DM_3	P72_DM_3	P72	34	F	18.3	underweight	non-smoker	IBD	CD	IFX	Remsima	3	31	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L1	L4	CD	non-EIM	none	no_surgery	none	visit_3	2	week_6	6		17.01.2020	IV	5	no_5ASA	none	immunosupp	AZA	corticoids	Budesonid	yes	Caltrate	1.9	low	5.9	393	47.35	130	28	normal	0	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	hordeolum	NA	NA	no	L1
P72_DM_6	P72_DM_6	P72	34	F	18.3	underweight	non-smoker	IBD	CD	IFX	Remsima	3	31	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L1	L4	CD	non-EIM	none	no_surgery	none	visit_7	6	week_28	28		15.06.2020	IV	7	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Algifen	61.5	high	4.8	572	49	127	4420	significantly_increased	7.4	negative	3	3	CD		inactive	remission	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P72_DM_5	P72_DM_5	P72	34	F	18.3	underweight	non-smoker	IBD	CD	IFX	Remsima	3	31	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L1	L4	CD	non-EIM	none	no_surgery	none	NA		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA						NA		NA	NA		CD		NA	NA	NA	NA	responder	responder	NA	non-SAE	none	none	no	none	none	NA	NA	no	L1
P75_SM_1	P75_SM_1	P75	25	M	21	normal	non-smoker	IBD	CD	ADA	Hulio	5	20	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	13.11.2019	SC	160	no_5ASA	none	immunosupp	AZA	no_corticoids	none	no	none	17.4	high	6.3	328	93.8	154	767	significantly_increased	0	negative	0	0	CD		inactive	remission	baseline	baseline	responder	responder	baseline_response	non-SAE	none	none	no	none	none	start	start	no	L1
P75_SM_2	P75_SM_2	P75	25	M	21	normal	non-smoker	IBD	CD	ADA	Hulio	5	20	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_2	1	week_2	2		27.11.2019	SC	80	no_5ASA	none	immunosupp	AZA	no_corticoids	none	no	none		NA						NA		NA	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P75_SM_3	P75_SM_3	P75	25	M	20.7	normal	non-smoker	IBD	CD	ADA	Hulio	5	20	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_3	2	week_8	8		28.01.2020	SC	40	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Vigantol	0.7	low	5.5	263	66.19	153	15	normal	18.4	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	during_Christmas_ATB_(angina)	NA	NA	no	L1
P75_SM_4	P75_SM_4	P75	25	M	20.7	normal	non-smoker	IBD	CD	ADA	Hulio	5	20	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_4	3	week_14	14		10.03.2020	SC	40	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Vigantol	0.5	low	5.8	273	47.78	155	7	normal	20	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P75_SM_7	P75_SM_7	P75	25	M	20.7	normal	non-smoker	IBD	CD	ADA	Hulio	5	20	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_7	6	week_32	32		15.07.2020	SC	40	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	none	1.1	low	5.2	276	37	146	20	normal	12.2	negative	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P75_SM_8	P75_SM_8	P75	25	M	20.7	normal	non-smoker	IBD	CD	ADA	Hulio	5	20	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_8	7	week_38	38		26.08.2020	SC	41	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	none	0.5	low	7.4	267	46	144	20	normal	11.5	negative	1	1	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	end	end	no	L1
P74_KP_1	P74_KP_1	P74	27	F	24.2	normal	non-smoker	IBD	UC	IFX	Remsima	1	26	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E1	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	12.11.2019	IV	5	no_5ASA	none	immunosupp	AZA	corticoids	Budesonid	yes	Salofalk_supp_Budenofalk	1.4	low	5.4	197	4.33	134	479	significantly_increased	0	negative	UC		7	7	active	moderate	baseline	baseline	partial-responder	responder	baseline_partial_response	non-SAE	none	none	no	none	none	start	start	no	E1
P74_KP_2	P74_KP_2	P74	27	F	24.2	normal	non-smoker	IBD	UC	IFX	Remsima	1	26	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E1	non-EIM	none	no_surgery	none	visit_2	1	week_2	2		26.11.2019	IV	5	no_5ASA	none	immunosupp	AZA	corticoids	Budesonid	yes	Salofalk_supp_Budenofalk	0.7	low	5.1	182	6.14	130	38	normal	20	negative	UC		3	3	inactive	mild	response	full_response	partial-responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E1
P74_KP_4	P74_KP_4	P74	27	F	25.4	overweight	non-smoker	IBD	UC	IFX	Remsima	1	26	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E1	non-EIM	none	no_surgery	none	visit_4	3	week_14	14		11.03.2020	IV	5	no_5ASA	none	immunosupp	AZA	no_corticoids	none	no	none	1	low	4.1	173	7.07	141	897	significantly_increased	5.2	negative	UC		4	4	inactive	mild	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	E1
P74_KP_5	P74_KP_5	P74	27	F	25.4	overweight	non-smoker	IBD	UC	IFX	Remsima	1	26	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E1	non-EIM	none	no_surgery	none	visit_5	4	week_22	22		07.05.2020	IV	5	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Budenofalk	2	low	5.5	164	9.81	133	396	significantly_increased	3	negative	UC		3	3	inactive	mild	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	E1
P74_KP7	P74_KP7	P74	27	F	25.4	overweight	non-smoker	IBD	UC	IFX	Remsima	1	26	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E1	non-EIM	none	no_surgery	none	visit_8	7	week_38	38		14.08.2020	IV	5	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	none	0.5	low	4.8	161	10	133		NA	7.8	negative	UC		3	3	inactive	mild	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	end	end	no	E1
P77_VJ_1	P77_VJ_1	P77	35	F	25	normal	non-smoker	IBD	UC	ADA	Hulio	12	23	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	14.11.2019	SC	160	5ASA	Salofalk	no_immunosupp	none	corticoids	Prednison	yes	Prestarium_Betaloc_Nolpaza	3.7	low	12.6	406	17.95	126	845	significantly_increased	0	negative	UC		3	3	inactive	mild	baseline	baseline	partial-responder	responder	baseline_partial_response	non-SAE	none	none	no	none	none	start	start	no	E3
26_HP_1	26_HP_1	P26	42	F	21.1	normal	non-smoker	IBD	UC	IFX	Remsima	20	22	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	18.02.2019	IV	5	5ASA	Pentasa	no_immunosupp	none	corticoids	Medrol	yes	Helicid	71.8	high	23.7	633	51.14	110	3388	significantly_increased	0	negative	UC		9	9	active	severe	baseline	baseline	non-responder	non-responder	baseline_no_response	non-SAE	none	none	no	none	none	start	start	no	E3
P77_VJ_3	P77_VJ_3	P77	35	F	25.4	overweight	non-smoker	IBD	UC	ADA	Hulio	12	23	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_3	2	week_8	8		08.01.2020	SC	40	5ASA	Salofalk	no_immunosupp	none	no_corticoids	none	yes	Prestarium_Betaloc_Nolpaza	1.3	low	11.4	428	17.47	134	249	significantly_increased	20	negative	UC		3	3	inactive	remission	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	E3
P78_BL_1	P78_BL_1	P78	61	M	29.7	overweight	non-smoker	IBD	CD	ADA	Imraldi	31	30	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B3	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_1	0	week_0	0	0	19.11.2019	SC	160	5ASA	Pentasa	no_immunosupp	none	corticoids	Medrol	no	none	1.2	low	7.6	320	155.75	166	106	slightly_increased	0	negative	5	5	CD		inactive	mild	baseline	baseline	responder	responder	baseline_response	non-SAE	none	none	no	none	none	start	start	no	L3
P78_BL_2	P78_BL_2	P78	61	M	29.7	overweight	non-smoker	IBD	CD	ADA	Imraldi	31	30	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B3	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_2	1	week_2	2		03.12.2019	SC	80	5ASA	Pentasa	no_immunosupp	none	corticoids	Medrol	yes	Caltrate	0.9	low	7.2	257	96.68	168	35	normal	18.3	negative	2	2	CD		inactive	remission	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
P78_BL_3	P78_BL_3	P78	61	M	29.7	overweight	non-smoker	IBD	CD	ADA	Imraldi	31	30	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B3	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_3	2	week_8	8		14.01.2020	SC	40	5ASA	Pentasa	no_immunosupp	none	corticoids	Medrol	yes	Caltrate_Betasec	8.6	low	5.9	240	114.12	165		NA	20	negative	1	1	CD		inactive	remission	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L3
P78_BL_4	P78_BL_4	P78	61	M	29.7	overweight	non-smoker	IBD	CD	ADA	Imraldi	31	30	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B3	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_4	3	week_14	14		25.02.2020	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	yes	Caltrate_Betasec	0.9	low	6.9	243	91.17	164	71	slightly_increased	8.1	negative	1	1	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L3
P78_BL_6	P78_BL_6	P78	61	M	29.7	overweight	non-smoker	IBD	CD	ADA	Imraldi	31	30	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B3	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_6	5	week_26	26		30.06.2020	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	yes	Caltrate_Betasec	1.7	low	5.9	257	92	158	20	normal	7.3	negative	1	1	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L3
P78_BL_8	P78_BL_8	P78	61	M	29.7	overweight	non-smoker	IBD	CD	ADA	Imraldi	31	30	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B3	L3	non-L4	CD	EIM	joints	no_surgery	none	visit_8	7	week_38	38		25.08.2020	SC	40	5ASA	Pentasa	no_immunosupp	none	corticoids	Medrol	yes	"Caltrate,_Betasec,_Alfuzosin,_Detralex"	0.5	low	6	225	56	166	38	normal	7.6	negative	1	1	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	end	end	no	L3
28_WL_1_IFX	28_WL_1_IFX	P28_IFX	35	F	18.3	underweight	non-smoker	IBD	CD	IFX	Remsima	7	28	yes	seronegative_spondyloarthritis	EIM	repet_biothrp	ADA	A2	B1	L1	non-L4	CD	EIM	joints	no_surgery	none	visit_1	0	week_0	0	0	18.07.2019	IV	5	no_5ASA	none	immunosupp	MTX	corticoids	Hydrokortizon	yes	Omeprazol_Calcichew_folate_Vigantol_Euthyrox_Doreta_Ultarcod_Nutridrink_Mutaflor	0.4	low	12.4	416	13.47	118	300	significantly_increased	0	negative	7	7	CD		inactive	mild	baseline	baseline	partial-responder	responder	baseline_partial_response	non-SAE	none	none	no	none	none	start	start	no	L1
28_WL_2_IFX	28_WL_2_IFX	P28_IFX	35	F	18.3	underweight	non-smoker	IBD	CD	IFX	Remsima	7	28	yes	seronegative_spondyloarthritis	EIM	repet_biothrp	ADA	A2	B1	L1	non-L4	CD	EIM	joints	no_surgery	none	visit_2	1	week_2	2		02.08.2019	IV	5	no_5ASA	none	immunosupp	MTX	corticoids	Hydrokortizon	yes	Omeprazol_Calcichew_folate_Vigantol_Euthyrox_Doreta_Ultarcod_Nutridrink_Mutaflor	0.4	low	5.3	389	17.98	112	501	significantly_increased	20	negative	4	4	CD		inactive	remission	response	full_response	partial-responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
28_WL_4_IFX	28_WL_4_IFX	P28_IFX	35	F	19.1	normal	non-smoker	IBD	CD	IFX	Remsima	7	28	yes	seronegative_spondyloarthritis	EIM	repet_biothrp	ADA	A2	B1	L1	non-L4	CD	EIM	joints	no_surgery	none	visit_4	3	week_14	14		29.10.2019	IV	5	no_5ASA	none	immunosupp	MTX	corticoids	Hydrokortizon	yes	Omeprazol_Calcichew_folate_Vigantol_Euthyrox_Doreta_Ultarcod_Nutridrink_Mutaflor	0.3	low	6.8	334	15.24			NA	8.4	negative	4	4	CD		inactive	remission	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L1
28_WL_6_IFX	28_WL_6_IFX	P28_IFX	35	F	19.4	normal	non-smoker	IBD	CD	IFX	Remsima	7	28	yes	seronegative_spondyloarthritis	EIM	repet_biothrp	ADA	A2	B1	L1	non-L4	CD	EIM	joints	no_surgery	none	visit_7	6	week_30	30	0	09.01.2020	IV	5	no_5ASA	none	immunosupp	MTX	corticoids	Hydrokortizon	yes	Omeprazol_Calcichew_folate_Vigantol_Euthyrox_Doreta_Ultarcod_Nutridrink_Mutaflor	0.3	low	9.1	381	9.9	110	119	slightly_increased	17.2	negative	1	1	CD		inactive	remission	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P57_TV_1	P57_TV_1	P57	25	M	22.9	normal	non-smoker	IBD	CD	ADA	Hulio	4	21	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	10.09.2019	SC	160	no_5ASA	none	immunosupp	AZA	no_corticoids	none	no	none	6.2	low	7.1	280	94.25	139	713	significantly_increased	0	negative	0	0	CD		inactive	remission	baseline	baseline	responder	responder	baseline_response	non-SAE	none	none	no	none	none	start	start	no	L1
P57_TV_2	P57_TV_2	P57	25	M	24.9	normal	non-smoker	IBD	CD	ADA	Hulio	4	21	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_2	1	week_2	2		24.09.2019	SC	80	no_5ASA	none	immunosupp	AZA	no_corticoids	none	no	none	0.9	low	5.5	287	93.72	147	139	slightly_increased	20	positive	0	0	CD		inactive	remission	response	partial_response	responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P57_TV_3	P57_TV_3	P57	25	M	24.9	normal	non-smoker	IBD	CD	ADA	Hulio	4	21	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_3	2	week_8	8		08.11.2019	SC	40	no_5ASA	none	immunosupp	AZA	no_corticoids	none	no	none	0.6	low	5.2	221	110.05	145	144	slightly_increased	13.7	positive	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P57_TV_4	P57_TV_4	P57	25	M	24.9	normal	non-smoker	IBD	CD	ADA	Hulio	4	21	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_4	3	week_14	14		20.12.2019	SC	40	no_5ASA	none	immunosupp	AZA	no_corticoids	none	no	none		NA						NA		NA	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P57_TV_5	P57_TV_5	P57	25	M	24.9	normal	non-smoker	IBD	CD	ADA	Hulio	4	21	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_5	4	week_20	20	0	03.02.2020	SC	40	no_5ASA	none	immunosupp	AZA	no_corticoids	none	no	none	1.1	low	5.7	219	65.11	136	55	slightly_increased	14.4	positive	1	1	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P57_TV_6	P57_TV_6	P57	25	M	24.9	normal	non-smoker	IBD	CD	ADA	Hulio	4	21	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_6	5	week_26	26		13.03.2020	SC	40	no_5ASA	none	immunosupp	AZA	no_corticoids	none	no	none	1.3	low	7.3	247	74.19	143		NA	14.4	positive	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P57_TV_7	P57_TV_7	P57	25	M	24.9	normal	non-smoker	IBD	CD	ADA	Hulio	4	21	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_7	6	week_32	32		22.04.2020	SC	40	no_5ASA	none	immunosupp	AZA	no_corticoids	none	no	none		NA					157	slightly_increased		NA	1	1	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	end	end	no	L1
P65_KS_6	P65_KS_6	P65	48	F	39	obesity	non-smoker	IBD	UC	IFX	Remsima	6	42	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_7	6	week_30	30	0	21.04.2020	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Calcichew_Cipralex	0.6	low	6.4	275	22.96	138	6	normal	14.6	negative	UC		2	2	inactive	mild	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E3
P24_IK_DR_1	P24_IK_DR_1	P24_IK	41	M	27.4	overweight	smoker	IBD	CD	ADA	Humira	4	37	yes	cystic_disease_of_liver_and__kidney	active_multilevel_inflammation	repet_biothrp	IFX	A3	B1	L1	non-L4	CD	EIM	joints	no_surgery	none	visit_extra		week_x			16.07.2019	SC	40	5ASA	NA	no_immunosupp	none	no_corticoids	none	no	none	49.5	high	8.4	203	145	138	815	significantly_increased		NA	4	4	CD		inactive	mild	response	full_response	NA	NA	NA	SAE	other	none	yes	"palm,feet"	longterm-treatment_11-2018_switch_from_IFX_to_ADA_for_severe_sae	NA	NA	no	L1
P24_IK_DR_2	P24_IK_DR_2	P24_IK	41	M	27.7	overweight	smoker	IBD	CD	ADA	Humira	4	37	yes	cystic_disease_of_liver_and__kidney	active_multilevel_inflammation	repet_biothrp	IFX	A3	B1	L1	non-L4	CD	EIM	joints	no_surgery	none	visit_extra		week_x			08.10.2019	SC	40	5ASA	NA	no_immunosupp	none	no_corticoids	none	no	none	6.3	low	8.8	279	87	148	451	significantly_increased		NA	4	4	CD		inactive	mild	response	full_response	NA	NA	NA	SAE	other	none	yes	"palm,feet"	longterm-treatment_11-2018_switch_from_IFX_to_ADA_for_severe_sae	NA	NA	no	L1
P24_IK_DR_3	P24_IK_DR_3	P24_IK	41	M	27.7	overweight	smoker	IBD	CD	ADA	Humira	4	37	yes	cystic_disease_of_liver_and__kidney	active_multilevel_inflammation	repet_biothrp	IFX	A3	B1	L1	non-L4	CD	EIM	joints	no_surgery	none	visit_extra		week_x			17.12.2019	SC	40	5ASA	NA	no_immunosupp	none	no_corticoids	none	no	none	5.6	low	8.3	255	78.4	147	187	slightly_increased		NA	4	4	CD		inactive	mild	response	full_response	NA	NA	NA	SAE	other	none	yes	"palm,feet"	longterm-treatment_11-2018_switch_from_IFX_to_ADA_for_severe_sae	NA	NA	no	L1
P24_IK_DR_4	P24_IK_DR_4	P24_IK	42	M	27.7	overweight	smoker	IBD	CD	ADA	Humira	4	37	yes	cystic_disease_of_liver_and__kidney	active_multilevel_inflammation	repet_biothrp	IFX	A3	B1	L1	non-L4	CD	EIM	joints	no_surgery	none	visit_extra		week_x			10.03.2020	SC	40	5ASA	NA	no_immunosupp	none	no_corticoids	none	no	none	4.5	low	8.4	265	77	146	874	significantly_increased		NA	4	4	CD		inactive	mild	response	full_response	NA	NA	NA	SAE	other	none	yes	"palm,feet"	longterm-treatment_11-2018_switch_from_IFX_to_ADA_for_severe_sae	NA	NA	no	L1
P53_CZ_6	P53_CZ_6	P53	41	F	29.3	overweight	smoker	IBD	CD	IFX	Remsima	2	39	no	none	perianal_disease	first_biothrp	none	A2	B3	L1	non-L4	CD	non-EIM	none	surgery	drainage	visit_7	6	week_30	30	0	15.04.2020	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Omeprazol_Caltrate		NA					107	slightly_increased		NA	3	3	CD		inactive	remission	response	full_response	partial-responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P56_SP_4	P56_SP_4	P56	22	F	20.8	normal	non-smoker	IBD	UC	IFX	Remsima	1	20	yes	hypothyroidism	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_4	3	week_14	14		16.12.2019	IV	5	no_5ASA	none	immunosupp	AZA	no_corticoids	none	yes	Letrox	0.4	low	5.9	265	1.98	95	869	significantly_increased	10	negative	UC		3	3	inactive	mild	response	full_response	partial-responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E3
P66_CR_6	P66_CR_6	P66	31	M	24	normal	non-smoker	IBD	CD	IFX	Remsima	4	27	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_7	6	week_30	30	0	30.04.2020	IV	5	no_5ASA	none	immunosupp	MTX	no_corticoids	none	yes	Caltrate_folate_Vigantol	0.7	low	4.2	200	86.59	169	14	normal	4.8	negative	1	1	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P71_SJ_5	P71_SJ_5	P71	29	F	24	normal	non-smoker	IBD	CD	ADA	Imraldi	3	26	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_6	5	week_26	26		29.04.2020	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	0.8	low	6.1	377	4.2	110	247	significantly_increased	15.1	negative	4	4	CD		inactive	remission	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	NA	NA	no	L1
P77_5J_8	P77_VJ_8	P77	35	F	26.1	overweight	non-smoker	IBD	UC	ADA	Hulio	12	23	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_8	7	week_38	38		29.09.2020	SC	41	5ASA	Salofalk	no_immunosupp	none	no_corticoids	none	yes	"Prestarium,_Betaloc,_HAK"	18.3	high	13.8	499	37	116	245	significantly_increased	2.3	NA	UC		3	3	inactive	remission	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	end	end	no	E3
28_WL_7_IFX	28_WL_7_IFX	P28_IFX	35	F	19.4	normal	non-smoker	IBD	CD	IFX	Remsima	7	28	yes	seronegative_spondyloarthritis	EIM	repet_biothrp	ADA	A2	B1	L1	non-L4	CD	EIM	joints	no_surgery	none	visit_8	7	week_38	38		30.03.2020	IV	5	no_5ASA	none	immunosupp	MTX	corticoids	Hydrokortizon	yes	Omeprazol_Calcichew_folate_Vigantol_Euthyrox_Doreta_Ultarcod_Nutridrink_Mutaflor_Sulfasalazin	0.2	low	5.3	298	9.73	107		NA	12.2	negative	4	4	CD		inactive	remission	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	end	end	no	L1
55_z_510200	55_z_510200	P55	28	M	26.9	overweight	non-smoker	IBD	CD	IFX	Remsima	5	23	no	none	post-operative_relaps	first_biothrp	none	A2	B3	L1	non-L4	CD	non-EIM	none	surgery	ileocecal_resection	visit_extra		week_x			09.09.2019	IV	7	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Vasosan	1.3	low	6.9	308	107.84	152	6	normal	7.5	negative	0	0	CD		inactive	remission	response	full_response	NA	NA	NA	SAE	none	none	yes	mycosis-like_skin_lesion_on_the_thigh	mycosis-like_skin_lesion_on_the_thigh	NA	NA	SAE_only	L1
P7_IK_JP_2	P7_IK_JP_2	P7_IK	22	M	27.8	overweight	non-smoker	IBD	CD	IFX	Flixabi	0	22	no	none	perianal_disease	first_biothrp	none	A2	B3	L3	L4	CD	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	05.02.2019	NA	NA	no_5ASA	none	no_immunosupp	none	corticoids	NA	no	none	0	low	23.4	288		147	702	significantly_increased		negative	5	5	CD		inactive	mild	baseline	baseline	NA	NA	NA	NA	none	none	no	none	none	start	start	no	L3
P7_IK_JP_3	P7_IK_JP_3	P7_IK	23	M	29.3	overweight	non-smoker	IBD	CD	IFX	Flixabi	1	22	no	none	perianal_disease	first_biothrp	none	A3	B3	L3	L4	CD	non-EIM	none	surgery	drainage	visit_7	6	week_30	30	0	05.09.2019	IV	40	no_5ASA	none	immunosupp	AZA	corticoids	NA	no	none	0	low	16.6	225	83.6	150	47	normal		NA	2	2	CD		inactive	remission	response	full_response	NA	NA	NA	NA	none	none	no	none	none	end	end	no	L3
P25_IK_LD_1	P25_IK_LD_1	P25_IK	29	M	24.2	normal	non-smoker	IBD	UC	IFX	Flixabi	1	28	no	none	corticosteroid_course_of_UC	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_1	0	week_0	0	0	18.07.2019	IV	500	5ASA	NA	immunosupp	AZA	corticoids	NA	yes	Omeprazol	13.2	high	9.8	380	43.1	136	298	significantly_increased	0	negative	UC		7	7	active	moderate	baseline	baseline	responder	responder	baseline_response	non-SAE	none	none	no	none	none	start	start	no	E3
P25_IK_LD_3	P25_IK_LD_3	P25_IK	29	M	24.4	normal	non-smoker	IBD	UC	IFX	Flixabi	1	28	no	none	corticosteroid_course_of_UC	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_5	4	week_22	22		07.11.2019	IV	500	5ASA	NA	immunosupp	AZA	corticoids	NA	yes	Omeprazol	0.6	low	4.9	274	123	150	22	normal	10.5	negative	UC		2	2	inactive	mild	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	E3
P25_IK_LD_4	P25_IK_LD_4	P25_IK	29	M	24.4	normal	non-smoker	IBD	UC	IFX	Flixabi	1	28	no	none	corticosteroid_course_of_UC	first_biothrp	none	A2	UC	UC	UC	E3	non-EIM	none	no_surgery	none	visit_8	7	week_38	38		04.03.2020	IV	500	5ASA	NA	immunosupp	AZA	corticoids	NA	yes	Omeprazol	0.9	low	4.4	247	169	144	18	normal		NA	UC		2	2	inactive	mild	response	full_response	responder	responder	response	non-SAE	none	none	no	none	none	end	end	no	E3
K17_1	K17_1	HC17	43	F	21.6	normal	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	06.05.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K17_2	K17_2	HC17	43	F	21.6	normal	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_2	1	week_2	2		21.05.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K17_3	K17_3	HC17	43	F	21.6	normal	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_3	2	week_26	26		12.11.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K17_4	K17_4	HC17	43	F	21.6	normal	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_4	3	week_28	28		25.11.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K1_1	K1_1	HC1	47	M	25.8	overweight	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	15.04.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K1_2	K1_2	HC1	47	M	25.8	overweight	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_2	1	week_2	2		29.04.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K1_3	K1_3	HC1	47	M	25.8	overweight	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_3	2	week_26	26		01.10.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K1_4	K1_4	HC1	47	M	25.8	overweight	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_4	3	week_28	28		14.10.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K20_1	K20_1	HC20	43	F	27.3	overweight	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	09.05.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K20_2	K20_2	HC20	43	F	27.3	overweight	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_2	1	week_2	2		21.05.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K20_3	K20_3	HC20	43	F	27.3	overweight	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_3	2	week_26	26		01.01.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K20_4	K20_4	HC20	43	F	27.3	overweight	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_4	3	week_28	28		12.11.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K19_1	K19_1	HC19	45	M	25.1	overweight	smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	07.05.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K19_2	K19_2	HC19	45	M	25.1	overweight	smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_2	1	week_2	2		22.05.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K19_3	K19_3	HC19	45	M	25.1	overweight	smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_3	2	week_26	26		01.01.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K19_4	K19_4	HC19	45	M	25.1	overweight	smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_4	3	week_28	28		12.11.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K11_1	K11_1	HC11	31	M	20	normal	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	18.04.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K11_2	K11_2	HC11	31	M	20	normal	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_2	1	week_2	2		30.04.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K11_3	K11_3	HC11	31	M	20	normal	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_3	2	week_26	26		14.10.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K11_4	K11_4	HC11	31	M	20	normal	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_4	3	week_28	28		24.10.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K9_1	K9_1	HC9	39	F	21.8	normal	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	18.04.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K9_2	K9_2	HC9	39	F	21.8	normal	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_2	1	week_2	2		06.05.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K9_3	K9_3	HC9	39	F	21.8	normal	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_3	2	week_26	26		01.10.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K9_4	K9_4	HC9	39	F	21.8	normal	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_4	3	week_28	28		14.10.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K32_1	K32_1	HC32	29	F	21.6	normal	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	25.06.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K28_1	K28_1	HC28	36	M	24.9	normal	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	18.06.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K27_1	K27_1	HC27	37	M	20.5	normal	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	05.06.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K26_1	K26_1	HC26	27	M	21.5	normal	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	18.06.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K21_1	K21_1	HC21	33	M	19.5	normal	smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	16.05.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K24_1	K24_1	HC24	29	M	20.7	normal	smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	28.05.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K22_1	K22_1	HC22	51	F	29.3	overweight	smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	28.05.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
K23_1	K23_1	HC23	33	M	27.5	overweight	non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	visit_1	0	week_0	0	0	21.05.2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC		NA						NA	0	HC	HC		HC		HC	HC	HC	HC	HC	HC	HC	HC	none	none	no	none	none	NA	NA	no	HC
mock_4_bact	mock_4_bact	NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA						NA		NA	NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	no	NA
mock_4_DNA	mock_4_DNA	NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA						NA		NA	NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	no	NA
21_PP_8_ADA	21_PP_8_ADA	P21_ADA	25	F	23.5	normal	smoker	IBD	CD	ADA	Hulio	2	23	no	none	intensified_IFX_ineffectiveness_switch_without_washout	repet_biothrp	IFX	A2	B3	L3	non-L4	CD	EIM	joints	surgery	drainage	visit_8	7	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA						NA		NA	NA		CD		NA	NA	NA	NA	NA	NA	NA	non-SAE	none	none	no	none	"Rhinitis_since_March_2020-green_purulent_secretion_corticoids,_ATB_nasal_drops-no_effect,_allergy_excluded_(blood_and_skin_prick_tests)._In_the_last_week,_dry_cough_without_expectoration_or_temperatures._For_the_last_three_weeks,_herpes,_now_the_ragades_at_the_P_nostril,_prolonged_wound_healing,_gingivitis_subsided"	NA	NA	no	L3
P72_DM_7	P72_DM_7	P72	34	F	18.3	underweight	non-smoker	IBD	CD	IFX	Remsima	3	31	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B2	L1	L4	CD	non-EIM	none	no_surgery	none	visit_8	7	week_38	38		11.08.2020	IV	10	no_5ASA	none	immunosupp	AZA	corticoids	Budenofalk	yes	Emanera(PPI)_Algifen_Nutridrinks_diet_(CDED)	3.1	low	4.6	361	16	128	284	significantly_increased	3.2	NA	0	0	CD		inactive	remission	response	full_response	responder	responder	response	non-SAE	none	none	no	none	"Joint_pain,especially_after_last_application_of_BT,_crazy_knee_pain_at_night_and_once_more_again,_nevre_suffered_from_joint__pain_before"	end	end	no	L1
P53_CZ_8	P53_CZ_8	P53	41	F	28.9	overweight	smoker	IBD	CD	IFX	Remsima	2	39	no	none	perianal_disease	first_biothrp	none	A2	B3	L1	non-L4	CD	non-EIM	none	surgery	drainage	visit_9	8	week_46	46		07.08.2020	IV	5	no_5ASA	none	no_immunosupp	none	no_corticoids	none	yes	Omeprazol_Caltarte_Plaquenil	6.9	low	8.6	234	10	138	227	significantly_increased	1.7	positive	6	6	CD		inactive	mild	response	partial_response	partial-responder	responder	partial_response	non-SAE	none	none	no	none	none	end	end	no	L1
P71_SJ_9	P71_SJ_9	P71	29	F	24	normal	non-smoker	IBD	CD	ADA	Imraldi	3	26	no	none	conventional_therapy_ineffectiveness	first_biothrp	none	A2	B1	L1	non-L4	CD	non-EIM	none	no_surgery	none	visit_9	8	week_42	42		17.08.2020	SC	40	5ASA	Pentasa	no_immunosupp	none	no_corticoids	none	no	none	0.5	low	5.4	435	159	108	186	slightly_increased	7.2	NA	1	1	CD		inactive	remission	response	full_response	partial-responder	responder	response	non-SAE	none	none	no	none	none	NA	NA	no	L1